First-line NALIRIFOX superior to standard treatment in mPDAC

Prof. Zev Wainberg

First-line NALIRIFOX superior to standard treatment in mPDAC

Presented By

Prof. Zev Wainberg, University of California Los Angeles, CA, USA

Trial

Phase 3, NAPOLI-3

Conference

ASCO GI 2023

17 March, 2023 09:37

Novel approach delivers quality-of-life benefits for patients with pancreatic cancer

Presented By

Dr Yaacov Lawrence, Sheba Medical Center, Israel

Conference

ASCO GI 2023

17 March, 2023 09:34

Palliative radiation therapy improves hepatic pain in HCC and liver metastasis

Presented By

Prof. Laura Dawson, Princess Margaret Cancer Centre, Canada

Conference

ASCO GI 2023

17 March, 2023 09:30

Improved survival following postoperative sorafenib plus TACE in HCC

Presented By

Prof. Ming Kuang, The First Affiliated Hospital, China

Conference

ASCO GI 2023

17 March, 2023 09:28

Quality-of-life benefits for tislelizumab in uHCC

Presented By

Prof. Richard Finn, University of California Los Angeles, CA, USA

Trial

Phase 3, RATIONALE-301

Conference

ASCO GI 2023

17 March, 2023 09:26

Stereotactic body radiation therapy beneficial for patients with locally advanced HCC

Presented By

Prof. Laura Dawson, Princess Margaret Cancer Centre, Canada

Trial

Phase 3, NRG/RTOG1112

Conference

ASCO GI 2023

17 March, 2023 09:23

SWOG 1815, first-ever phase 3 trial in BTC, fails

Presented By

Prof. Rachna Shroff, University of Arizona Cancer Center, AZ, USA

Conference

ASCO GI 2023

17 March, 2023 09:20

IMbrave 151 missed primary endpoint in advanced BTC

Presented By

Prof. Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 2, IMbrave151

Conference

ASCO GI 2023

17 March, 2023 09:15

Acceptable safety profile and encouraging efficacy of nanvuranlat in BTC

Presented By

Dr Junji Furuse, Kanagawa Cancer Center, Japan

Conference

ASCO GI 2023

17 March, 2023 09:11

Combination botensilimab plus balstilimab demonstrates promising activity in heavily pre-treated MSS CRC

Presented By

Prof. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 1, C-800

Conference

ASCO GI 2023

17 March, 2023 09:06

Mutation-based selection to identify patients suitable for panitumumab treatment

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO GI 2023

17 March, 2023 09:01

Fucoidan associated with quality-of-life benefits in patients with rectal cancer receiving CCRT

Presented By

Prof. Jaw-Yuan Wang, Pingtung Hospital, Taiwan

Conference

ASCO GI 2023

17 March, 2023 08:58

ctDNA appears useful in monitoring patients with anal cancer undergoing CRT

Presented By

Dr Janet Alvarez, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO GI 2023

17 March, 2023 08:55

SUNLIGHT trial meets primary endpoint in refractory metastatic CRC

Presented By

Prof. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain

Trial

Phase 3, SUNLIGHT

Conference

ASCO GI 2023

17 March, 2023 08:45

Does cell-free DNA influence MRD testing in post-operative colon cancer?

Presented By

Dr Stacey Cohen, University of Washington, WA, USA

Conference

ASCO GI 2023

17 March, 2023 08:41

OPERA: surgery may be avoided with adequate therapy in rectal cancer

Presented By

Prof. Arthur Sun Myint, Clatterbridge Cancer Centre, UK

Trial

Phase 3, OPERA

Conference

ASCO GI 2023

17 March, 2023 08:39

Can we improve total neoadjuvant therapy for rectal cancer?

Presented By

Dr Thomas George, University of Florida, FL, USA

Trial

Phase 2, NRG-GI002

Conference

ASCO GI 2023

17 March, 2023 08:36

Zolbetuximab plus mFOLFOX6 successful in CLDN18.2-positive subgroup of gastric cancer

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, SPOTLIGHT

Conference

ASCO GI 2023

17 March, 2023 08:31

Regorafenib offers survival benefit for patients with pre-treated gastric cancer

Presented By

Prof. Nick Pavlakis, University of Sydney, Australia

Trial

Phase 3, INTEGRATE IIa

Conference

ASCO GI 2023

17 March, 2023 08:24

Radiotherapy or not in locally advanced oesophageal or junctional cancer?

Presented By

Prof. Maeve Lowery, St James’s Hospital, Ireland

Trial

Phase 3, Neo-AEGIS

Conference

ASCO GI 2023

17 March, 2023 08:20

Neoadjuvant immunotherapy is safe and efficacious in a phase 2 gastric cancer trial

Presented By

Dr Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

Trial

Phase 2, INFINITY

Conference

ASCO GI 2023

17 March, 2023 08:19

S-1 adjuvant chemotherapy: 4 or 8 courses in stage 2 gastric cancer?

Presented By

Dr Souya Nunobe, Cancer Institute Hospital, Japan

Trial

Phase 3, OPAS-1

Conference

ASCO GI 2023

17 March, 2023 08:18

LATG/LAPG demonstrates excellent long-term efficacy in stage 1 gastric cancer

Presented By

Dr Shinichi Sakuramoto, Saitama Medical University International Medical Center, Japan

Trial

JCOG1401

Conference

ASCO GI 2023

17 March, 2023 08:15

3-year follow-up data confirms benefits of nivolumab plus chemotherapy

Presented By

Dr Yelena Janjigian, Memorial Sloan Kettering Cancer, NY, USA

Trial

Phase 3, CheckMate 649

Conference

ASCO GI 2023

17 March, 2023 08:10

Long-term results for nivolumab plus chemotherapy and nivolumab plus ipilimumab in oesophageal cancer

Presented By

Dr Ken Kato, National Cancer Center Hospital, Japan

Trial

Phase 3, CheckMate 648

Conference

ASCO GI 2023

17 March, 2023 08:02

Promising phase 2 results for HER-Vaxx in gastric cancer

Presented By

Dr Tanuj Chawla, Tata Medical Center, India

Trial

Phase 2, HERIZON

Conference

ASCO GI 2023

17 March, 2023 08:00

C1 inhibitor deficiency linked to thrombosis

Presented By

Dr Steven Grover, University of North Carolina, NC, USA

Conference

ASH 2022

20 February, 2023 13:18

Durable responses to gene therapy in haemophilia A

Presented By

Prof. Stacy Croteau, Harvard Medical School, MA, USA

Trial

Phase 1/2, SPK-8011

Conference

ASH 2022

20 February, 2023 13:16

Long-term benefits from beti-cel in transfusion-dependent β-thalassaemia

Presented By

Prof. Mark Walters; Prof. Franco Locatelli

Trial

LTF-303

Conference

ASH 2022

20 February, 2023 13:14

Neutrodiet: non-restricted diet is the preferred option after SCT

Presented By

Prof. Federico Stella, Università degli Studi di Milano, Italy

Conference

ASH 2022

20 February, 2023 13:11

Iptacopan offers solution for patients with PNH and residual anaemia after standard-of-care

Presented By

Prof. Régis de Latour, Saint-Louis Hospital, France

Trial

Phase 3, Apply-PNH

Conference

ASH 2022

20 February, 2023 13:09

Novel therapy may replace standard-of-care prophylaxis for GVHD

Presented By

Prof. Shernan Holtan, University of Minnesota, MN, USA

Trial

Phase 3, BMT CTN 1703

Conference

ASH 2022

20 February, 2023 13:05

LMWH does not result in higher live birth rates in women with inherited thrombophilia

Presented By

Prof. Saskia Middeldorp, Radboud UMC, the Netherlands

Trial

ALIFE2

Conference

ASH 2022

20 February, 2023 13:01

Efgartigimod successful in immune thrombocytopenia

Presented By

Prof. Catherine Broome, Georgetown University, Washington DC, USA

Trial

Phase 3, ADVANCE

Conference

ASH 2022

20 February, 2023 12:57

Long-term risk for haematologic disease in persistent, isolated mild thrombocytopenia

Presented By

Dr Nardeen Ayad, Massachusetts General Hospital, MA, USA

Conference

ASH 2022

20 February, 2023 12:50

INCA033989: novel investigational agent for CALR-mutated MPN

Presented By

Dr Edimara Reis, Incyte Corporation, DE, USA

Conference

ASH 2022

20 February, 2023 12:47

Ruxolitinib mediates clonal evolution of RAS pathway mutations in MPN

Presented By

Dr Nabih Maslah, Université Paris Cité, France

Conference

ASH 2022

20 February, 2023 12:43

Ibrutinib added to ASCT improves clinical outcomes in mantle cell lymphoma

Presented By

Prof. Martin Dreyling, University Hospital Munich, Germany

Trial

Phase 3, Triangle

Conference

ASH 2022

20 February, 2023 12:39

High-dose chemotherapy plus ASCT superior to standard immuno-chemotherapy in primary CNS lymphoma

Presented By

Prof. Gerald Illerhaus, Klinikum Stuttgart, Germany

Trial

Phase 3, MATRix/IELSG43

Conference

ASH 2022

20 February, 2023 12:37

Odronextamab has considerable anti-tumour effects in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Presented By

Prof. Won-Seog Kim, Samsung Medical Center, South Korea

Trial

Phase 2, ELM-2 trial

Conference

ASH 2022

20 February, 2023 12:30

Excellent results for AFM13-complexed NK cells in CD30-positive lymphoma

Presented By

Dr Yago Nieto, University of Texas, TX, USA

Conference

ASH 2022

20 February, 2023 12:27

CAR-Hematotox score predicts toxicity, infections, and clinical outcomes in MCL

Presented By

Dr Kai Rejeski, LMU Munich, Germany

Conference

ASH 2022

20 February, 2023 12:23

Talquetamab further investigated in heavily pre-treated MM after promising phase 2 data

Presented By

Prof. Ajai Chari, Mount Sinai School of Medicine, NY, USA

Trial

Phase 1/2, MonumenTAL-1

Conference

ASH 2022

20 February, 2023 12:19

Promising results of elranatamab for MM in phase 2 MagnetisMM-3 trial

Presented By

Prof. Nizar Bahlis, University of Calgary, Canada

Trial

Phase 2, MagnetisMM-3

Conference

ASH 2022

20 February, 2023 12:09

Deep and durable responses for quadruple therapy in smouldering MM

Presented By

Prof. Shaji Kumar, Mayo Clinic, MN, USA

Trial

Phase 2, ASCENT

Conference

ASH 2022

20 February, 2023 12:04

Ultra-sensitive MRD assessment in MM with BloodFlow

Presented By

Dr Laura Notarfranchi, University of Parma, Italy

Trial

Phase 3, GEM2014MAIN

Conference

ASH 2022

20 February, 2023 11:55

CAR-Hematotox score proves useful in relapsed/refractory MM

Presented By

Dr Kai Rejeski, LMU Munich, Germany

Conference

ASH 2022

20 February, 2023 11:52

Head-to-head: VMP versus Rd in transplant-ineligible MM

Presented By

Dr Sara Bringhen, Università degli Studi di Torino, Italy

Trial

Phase 4, REAL-MM

Conference

ASH 2022

20 February, 2023 11:47

Zanubrutinib wins battle of BTK inhibitors in relapsed or refractory CLL/SLL

Presented By

Prof. Jennifer Brown, Dana Farber Cancer Institute, MA, USA

Trial

Phase 3, ALPINE

Conference

ASH 2022

20 February, 2023 11:40

Ibrutinib plus venetoclax displays long-term benefits in CLL

Presented By

Prof. John Allan, Weill Cornell Medicine, NY, USA

Trial

Phase 2, CAPTIVATE

Conference

ASH 2022

20 February, 2023 11:28

Excellent results for triplet regimen in FLT3-mutated AML

Presented By

Prof. Nicholas Short, University of Texas, TX, USA

Conference

ASH 2022

20 February, 2023 11:25

MRD by qPCR prognostic of outcomes in venetoclax-treated NPM1-mutated AML

Presented By

Mr Jad Othman, Guy’s and St Thomas’ NHS Foundation Trust, UK

Conference

ASH 2022

20 February, 2023 11:20

Promising results for triplet therapy with magrolimab in AML

Presented By

Prof. Naval Daver, Anderson Cancer Center, TX, USA

Trial

Phase 3, ENHANCE-3

Conference

ASH 2022

20 February, 2023 11:17

Should we use intensive chemotherapy prior to allo-HCT in relapsed/refractory AML?

Presented By

Prof. Matthias Stelljes, University of Muenster, Germany

Trial

Phase 3, EATL3-ASAP

Conference

ASH 2022

20 February, 2023 11:13

Blinatumomab candidate for standard-of-care in newly diagnosed B-ALL

Presented By

Prof. Mark Litzow, Mayo Clinic, MN, USA

Trial

Phase 3, ECOG-ACRIN-E1910 NCTN

Conference

ASH 2022

20 February, 2023 11:07

High-dose methotrexate or standard interim maintenance in young patients with ALL?

Presented By

Ms Amy Kirkwood, University College London, UK

Trial

UKALL 2011

Conference

ASH 2022

20 February, 2023 11:01

Racial disparity in the tumour microenvironment

Presented By

Dr Burcu Karadal-Ferrena, Albert Einstein College of Medicine, NY, USA

Conference

SABCS 2022

1 February, 2023 18:42

Chemo-endocrine therapy worse for cognition than endocrine therapy alone

Presented By

Dr Irene Kang, City of Hope Orange County, CA, United States

Trial

RxPONDER PRO

Conference

SABCS 2022

1 February, 2023 18:36

Resistance to CDK4/6 inhibitors is likely due to expansion of pre-existing resistant clones

Presented By

Dr Cristina Guarducci, Dana-Farber Cancer Institute, MA, USA

Conference

SABCS 2022

1 February, 2023 18:32

Baseline CTC count can guide first-line treatment in HR-positive/HER-negative metastatic breast cancer

Presented By

Prof. François-Clément Bidard, Institut Curie, France

Trial

Phase 3, STIC CTC

Conference

SABCS 2022

1 February, 2023 18:30

Germline pathogenic variants for breast cancer also increase contralateral breast cancer risk

Presented By

Prof. Siddhartha Yadav, Mayo Clinic, MN, USA

Trial

CARRIERS

Conference

SABCS 2022

1 February, 2023 18:27

Low-dose tamoxifen still prevents recurrence from non-invasive breast cancer

Presented By

Dr Andrea De Censi, Ospedali Galliera, Italy

Trial

Phase 3, TAM-01

Conference

SABCS 2022

1 February, 2023 18:24

Endocrine interruption to pursue pregnancy does not impact short-term disease in breast cancer

Presented By

Dr Ann Partridge, Dana-Farber Cancer Institute, MA, USA

Trial

POSITIVE

Conference

SABCS 2022

1 February, 2023 18:22

ZNF689 deficiency promotes intratumour heterogeneity and resistance to immune checkpoint blockade in TNBC

Presented By

Dr Li-Peng Ge, Fudan University Shanghai Cancer Center, China

Conference

SABCS 2022

1 February, 2023 18:17

Oestradiol represses anti-tumoural immune response to promote progression of brain metastases

Presented By

Dr Maria Contreras-Zarate, University of Colorado, CO, USA

Conference

SABCS 2022

1 February, 2023 18:14

Benefit of adjuvant abemaciclib continues to deepen at longer follow-up

Presented By

Prof. Stephen Johnston, The Royal Marsden NHS Foundation Trust, UK

Trial

Phase 3, monarchE

Conference

SABCS 2022

1 February, 2023 18:10

First-line ribociclib plus endocrine therapy outperforms combination chemotherapy

Presented By

Dr Yen-Shen Lu, National Taiwan University Hospital, Taiwan

Trial

Phase 2, RIGHT Choice

Conference

SABCS 2022

1 February, 2023 18:07

Treatment options beyond CDK4/6 inhibition

Presented By

Dr Erica Mayer (Dana-Farber Cancer Institute, MA, USA); Prof. Virginia Kaklamani (University of Texas Health Sciences Center, TX, USA);

Trial

PACE; EMERALD; SERENA-2; CAPItello-291; VERITAC

Conference

SABCS 2022

1 February, 2023 18:03

Trastuzumab deruxtecan effective in both second-line and neoadjuvant setting

Presented By

Dr Ian Krop (Yale Cancer Center, CT, USA); Prof. Sara Hurvitz (David Geffen School of Medicine, CA, USA); Prof. Aditya Bardia (Harvard Medical School, MA, USA)

Trial

Phase 3, DESTINY-Breast02; DESTINY-Breast03; TRIO-US B-12 TALENT

Conference

SABCS 2022

1 February, 2023 17:51

Anti-PD-1/anti-LAG-3 combination highly effective in HER2-negative breast cancer

Presented By

Prof. Claudine Isaacs, Georgetown University Medical Center, DC, USA

Trial

Phase 2, I-SPY 2

Conference

SABCS 2022

1 February, 2023 17:42

MammaPrint test predictive for benefit of extended endocrine therapy

Presented By

Dr Laura van ‘t Veer, UCLA, CA, USA

Trial

Phase 3, IDEAL

Conference

SABCS 2022

1 February, 2023 17:32

IRONMAN failed primary endpoint but shows potential long-term benefits of iron repletion in HF patients

Presented By

Prof. Paul Kalra, University of Glasgow, UK

Trial

Phase 4, IRONMAN

Conference

AHA 2022

11 January, 2023 18:05

Up-titration of HF therapies following HF discharge saves lives

Presented By

Prof. Alexandre Mebazaa, Université Paris Cité, France

Trial

STRONG-HF

Conference

AHA 2022

11 January, 2023 17:57

The endothelin system: a new target for resistant high blood pressure

Presented By

Prof. Markus P Schlaich, University of Western Australia, Perth

Trial

Phase 3, PRECISION

Conference

AHA 2022

11 January, 2023 17:20

Can renal denervation lower BP on top of antihypertensive drugs?

Presented By

Dr David Kandzari, Piedmont Heart Institute, GA, USA

Trial

SPYRAL HTN-ON MED

Conference

AHA 2022

11 January, 2023 16:33

Quadruple, ultra-low-dose treatment did not meet primary endpoint in hypertension

Presented By

Dr Mark Huffman, Washington University School of Medicine, USA

Trial

QUARTET USA

Conference

AHA 2022

11 January, 2023 14:33

Mindfulness programme contributes to office blood pressure lowering

Presented By

Prof. Eric Loucks , Brown University, RI, USA

Trial

Phase 2, MB-BP

Conference

AHA 2022

11 January, 2023 14:28

Grafting with the radial vein: an underrated option in CABG surgery?

Presented By

Prof. David Hare , Austin Health, Australia

Trial

RAPCO

Conference

AHA 2022

11 January, 2023 14:25

Methylprednisolone does not reduce risk of adverse outcomes in infants undergoing heart surgery

Presented By

Dr Kevin Hill, Duke Children’s Hospital & Health Center, NC, USA

Trial

STRESS

Conference

AHA 2022

11 January, 2023 14:21

Extracorporeal membrane oxygenation not superior to conservative therapy in cardiogenic shock

Presented By

Prof. Petr Ostadal, Charles University, Czech Republic

Trial

ECMO-CS

Conference

AHA 2022

11 January, 2023 14:17

Surgery with adequate saphenous vein partly better than endovascular treatment in CLTI

Presented By

Dr Matthew Menard, Brigham and Women’s Hospital, MA, USA

Trial

BEST-CLI

Conference

AHA 2022

11 January, 2023 14:14

Doubling the dose of self-administered etripamil terminates PSVT

Presented By

Dr James Ip, Weill Cornell Medicine, NY, USA

Trial

Phase 3, RAPID

Conference

AHA 2022

11 January, 2023 14:05

Digitally delivered cognitive behavioural therapy successful in type 2 diabetes

Presented By

Prof. Marc Bonaca, University of Colorado, CO, USA

Trial

Phase 3, BT-001

Conference

AHA 2022

11 January, 2023 14:00

Empagliflozin reduces risk of kidney disease progression and CV events in patients with CKD

Presented By

Prof. David Preiss, University of Oxford, UK

Trial

Phase 3, EMPA-KIDNEY

Conference

AHA 2022

11 January, 2023 13:56

RESPECT-EPA misses primary endpoint but hints towards improvements in CV outcomes by EPA

Presented By

Dr Hiroyuki Daida, Juntendo University, Japan

Trial

RESPECT-EPA

Conference

AHA 2022

11 January, 2023 13:50

Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2022

11 January, 2023 13:46

Olpasiran leads to dramatic reductions in Lp(a) concentrations

Presented By

Prof. Michelle O´Donoghue, Brigham and Women's Hospital, MA, USA

Trial

Phase 2, OCEAN(a)-DOSE

Conference

AHA 2023

11 January, 2023 12:50

Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

SPORT

Conference

AHA 2022

11 January, 2023 12:45

No sex differences in lipid-lowering effect and treatment benefit of PCSK9 inhibitors

Presented By

Dr Frederick Rivera, Lincoln Medical Center, NY, USA

Conference

AHA 2022

11 January, 2023 12:40

‘No’ to routine use of rivaroxaban in outpatients with COVID-19

Presented By

Dr Gregory Piazza, Brigham and Women’s Hospital, MA, USA

Trial

PREVENT-HD

Conference

AHA 2022

11 January, 2023 12:21

COVID-19 pandemic: Older adults and those affected by the delta variant experienced increased cardiovascular morbidity and mortality

Presented By

Dr Pratyaksh Srivastava, Cedars-Sinai Medical Center, CA

Conference

AHA 2022

11 January, 2023 10:01

COVID-19 mRNA vaccination does not amplify risk of cardiovascular hospitalisation

Presented By

Dr Anthony Simone, Kaiser Permanente Los Angeles Medical Center, USA

Conference

AHA 2022

11 January, 2023 09:57

Higher LDL-cholesterol levels linked to higher CVD mortality risk in the elderly

Presented By

Dr Zhen Zhou, University of Tasmania, Australia

Trial

ASPREE

Conference

AHA 2022

11 January, 2023 09:53

AF: Moderate alcohol intake possibly associated with a reduced mortality risk

Presented By

Dr Alireza Oraii, Population Health Research Institute, Canada

Conference

AHA 2022

11 January, 2023 09:50

Periodontitis: An independent risk factor for AF

Presented By

Prof. Shunsuke Miyauchi, Hiroshima University, Japan

Conference

AHA 2022

11 January, 2023 09:46

Re-myelination strategies in MS still pose many unanswered questions

Presented By

Prof. Catherine Lubetzki, Sorbonne University, France

Conference

ECTRIMS 2022

20 December, 2022 12:01

MS associated with a broader Epstein-Barr virus specific T-cell receptor repertoire

Presented By

Dr Tilman Schneider-Hohendorf, University of Muenster, Germany

Conference

ECTRIMS 2022

20 December, 2022 11:58

Cognitive rehab and mindfulness reduce cognitive complaints in MS

Presented By

Dr Ilse Nauta, Vrije Universiteit Amsterdam, the Netherlands

Trial

REMIND-MS

Conference

ECTRIMS 2022

20 December, 2022 11:56

COVID-19 and MS: lessons learned thus far

Presented By

Prof. Céline Louapre, Sorbonne University, France

Trial

COVISEP

Conference

ECTRIMS 2022

20 December, 2022 11:52

Ocrelizumab and fingolimod increase the risk of COVID-19 and of worse outcomes

Presented By

Dr Nikos Evangelou, Nottingham University Hospital, UK

Conference

ECTRIMS 2022

20 December, 2022 11:46

Humoral and cellular immune responses after SARS-CoV-2 vaccination

Presented By

Dr Monika Rabenstein, Karolinska Institute, Sweden

Conference

ECTRIMS 2022

20 December, 2022 11:42

Ravulizumab significantly reduced relapses in AQP4+ NMOSD

Presented By

Dr Sean Pittock, Mayo Clinic, MN, USA

Trial

Phase 3, CHAMPION-NMOSD

Conference

ECTRIMS 2022

20 December, 2022 11:36

NMOSD patients are cognitively impaired regardless of serostatus

Presented By

Dr Martin Hümmert, Hannover Medical School, Germany

Conference

ECTRIMS 2022

20 December, 2022 11:25

Evidence-based consensus on pregnancy in NMOSD

Presented By

Prof. Sandra Vukusic, University Hospital Lyon, France

Conference

ECTRIMS 2022

20 December, 2022 10:34

Pregnancy and infant outcomes in women receiving ocrelizumab

Presented By

Prof. Celia Oreja-Guevara, University Hospital San Carlos, Spain

Conference

ECTRIMS 2022

20 December, 2022 10:29

New safety data of anti-CD20 mAbs around pregnancy

Presented By

Dr Carolin Schwake, Ruhr-University Bochum, Germany

Conference

ECTRIMS 2022

20 December, 2022 10:24

MS activity and pregnancy outcomes after long-term use of natalizumab

Presented By

Prof. Sandra Thiel, Ruhr University Bochum, Germany

Conference

ECTRIMS 2022

20 December, 2022 10:19

Early treatment with DMT effective in paediatric-onset MS

Presented By

Dr Emilio Portaccio, University of Florence, Italy

Conference

ECTRIMS 2022

20 December, 2022 09:55

Fingolimod in paediatric MS: results of up to 6 years

Presented By

Dr Kumaran Deiva, Paris South University Hospitals, France

Trial

Phase 3, PARADIGMS

Conference

ECTRIMS 2022

20 December, 2022 09:50

Switching treatment after initial platform injectable DMT: real-world data

Presented By

Dr Aaron Abrams, Cleveland clinic, OH, USA

Conference

ECTRIMS 2022

20 December, 2022 09:43

Stem cell transplantation not superior to natalizumab in progressive MS

Presented By

Prof. Tomas Kalincik, Royal Melbourne Hospital, Australia

Conference

ECTRIMS 2022

20 December, 2022 09:37

Efficacy of DMTs fades away in secondary progressive MS

Presented By

Dr Luigi Pontieri, The Danish Multiple Sclerosis Registry, Denmark

Conference

ECTRIMS 2022

20 December, 2022 09:32

Smartphone tapping can help detect progressive MS

Presented By

Dr Juan Luis Chico-Garcia, Hospital Ramon y Cajal, Spain

Conference

ECTRIMS 2022

20 December, 2022 09:19

Dimethyl fumarate reduces the risk of a first clinical event in RIS

Presented By

Prof. Darin Okuda, University of Texas Southwestern Medical Center, TX, USA

Trial

Phase 4, ARISE

Conference

ECTRIMS 2022

20 December, 2022 09:14

How and when to make a timely switch to high-efficacy DMT

Presented By

Dr Dalia Rotstein, University of Toronto, Canada

Conference

ECTRIMS 2022

20 December, 2022 09:08

Comparing real-world effectiveness of DMTs

Presented By

Prof. Marcello Moccia, University College London, UK

Conference

ECTRIMS 2022

20 December, 2022 09:05

Study fails to show non-inferiority of rituximab to ocrelizumab

Presented By

Dr Izanne Roos, University of Melbourne, Australia

Conference

ECTRIMS 2022

20 December, 2022 08:55

Autologous haematopoietic stem cell transplantation versus DMTs

Presented By

Prof. Tomas Kalincik, University of Melbourne, Australia

Conference

ECTRIMS 2022

20 December, 2022 08:52

A case for including optic nerve lesions in the McDonald criteria

Presented By

Prof. Frederik Barkhof, Vrije Universiteit Amsterdam, the Netherlands

Conference

ECTRIMS 2022

20 December, 2022 08:49

Cerebrospinal fluid kappa-free light chains for MS diagnosis

Presented By

Dr Harald Hegen, Medical University of Innsbruck, Austria

Conference

ECTRIMS 2022

19 December, 2022 19:19

Early, non-disabling relapses increase disability accumulation

Presented By

Dr Cyrus Daruwalla, Cambridge University Hospitals, UK

Conference

ECTRIMS 2022

19 December, 2022 19:13

Physical impairment is present before perceived MS onset

Presented By

Ms Annalaura Lerede, Imperial College London, UK

Conference

ECTRIMS 2022

19 December, 2022 19:09

Chronic active MS lesions respond poorly to anti-CD20 antibodies

Presented By

Dr Pietro Maggi, Saint-Luc University Hospital, Belgium

Conference

ECTRIMS 2022

19 December, 2022 19:06

Isuzinaxib effective in patients with CKD and T2D

Trial

Phase 2

Conference

ASN 2022

8 December, 2022 15:56

VALOR-CKD trial did not show any benefits for veverimer

Presented By

Dr Navdeep Tangri, Seven Oaks General Hospital, Winnipeg, Canada

Trial

Phase 3, VALOR-CKD

Conference

ASN 2022

8 December, 2022 15:54

EMPA-KIDNEY: empagliflozin slashes kidney disease progression or CV death

Presented By

Dr William Herrington, University of Oxford, UK

Trial

Phase 3, EMPA-KIDNEY

Conference

ASN 2022

8 December, 2022 15:53

Combining UACR and GFR improves prediction of drug effect in CKD phase 2 trials

Presented By

Dr Tom Greene, University of Utah, USA

Conference

ASN 2022

8 December, 2022 15:49

Dapagliflozin reduces number of hospitalisations in patients with CKD

Presented By

Dr Meir Schechter, Universitair Medisch Centrum Groningen, Netherlands

Trial

Phase 3, DAPA-CKD

Conference

ASN 2022

8 December, 2022 15:47

Novel MSC therapy appears safe and effective in preventing decline in eGFR

Presented By

Dr Matthew Griffin, University of Galway, Ireland

Trial

Phase 1/2, NEPHSTROM

Conference

ASN 2022

8 December, 2022 15:43

Dapagliflozin improves anaemia in patients with CKD with or without T2D

Presented By

Prof. Hiddo Heerspink, University of Groningen, Netherlands

Trial

Phase 3, DAPA-CKD

Conference

ASN 2022

8 December, 2022 15:39

Balanced crystalloid solution better for deceased donor kidney transplantations

Presented By

Dr Michel G. Collins, Royal Adelaide Hospital, Australia

Trial

BEST-Fluids

Conference

ASN 2022

8 December, 2022 15:36

Modified donor blood cells seem a promising option in kidney transplant recipients

Presented By

Dr Matthias Schaier, Heidelberg University, Germany

Trial

Phase 1

Conference

ASN 2022

8 December, 2022 15:34

Wearable serum potassium-monitoring device serves haemodialysis patients well

Conference

ASN 2022

8 December, 2022 15:22

Cooler dialysate does not offer any clinical benefits

Presented By

Prof. Amit Garg, London Health Sciences Centre and Western University, Ontario, Canada

Trial

MyTEMP

Conference

ASN 2022

8 December, 2022 15:20

Sodium zirconium cyclosilicate maintains pre-dialysis serum potassium

Trial

Phase 3, DIALIZE China

Conference

ASN 2022

8 December, 2022 15:18

Antiviral effect of MAU868 against BK virus prompts further research

Presented By

Dr Stanley Jordan, Cedars-Sinai Medical Center/Comprehensive Transplant Center, CA, USA

Trial

Phase 2

Conference

ASN 2022

8 December, 2022 15:16

Medication-targeted alerts for the risk of AKI

Presented By

Dr F. Perry Wilson, Yale School of Medicine, CT, USA

Conference

ASN 2022

8 December, 2022 15:13

Coaching with a DASH diet improves albuminuria

Presented By

Prof. Diedre C. Crews, Johns Hopkins University School of Medicine Equity, MD, USA

Trial

Five, Plus Nuts and Beans for Kidneys

Conference

ASN 2022

8 December, 2022 15:09

Cemdisiran shows promise in IgA nephropathy

Presented By

Prof. Jonathan Barratt, University of Leicester, UK

Trial

Phase 2

Conference

ASN 2022

8 December, 2022 14:58

Long-term nephroprotective effects of sparsentan in FSGS

Presented By

Dr Tarak Srivastava, Children’s Mercy Hospital, USA

Trial

Phase 2, DUET

Conference

ASN 2022

8 December, 2022 14:55

Encaleret normalises mineral homeostasis in patients with ADH1

Presented By

Dr Kelly Roszko, National Institutes of Health, USA

Trial

Phase 2

Conference

ASN 2022

8 December, 2022 14:52

Adding voclosporin to MMF and steroids results in long-term higher CRR in severe lupus nephritis

Presented By

Dr Hanni Menn-Josephy, Boston University School of Medicine, USA

Trial

AURORA 1, AURORA 2

Conference

ASN 2022

8 December, 2022 14:49

Selonsertib poses risk of AKI in patients with DKD

Presented By

Prof. Vlado Perkovic, University of New South Wales, Australia

Trial

Phase 2, MOSAIC

Conference

ASN 2022

8 December, 2022 14:34

Significantly higher risk of overcorrection in hyponatraemic patients with standard bolus infusion

Presented By

Dr Anissa Pelouto, Erasmus Medical Center, Rotterdam, the Netherlands

Conference

ASN 2022

8 December, 2022 14:29

Lowering blood pressure intervention favourable for CV outcomes

Presented By

Dr Amara Sarwal, University of Utah Health, UT, USA

Conference

ASN 2022

8 December, 2022 14:27

Immunotherapy response may be modulated by microbiome

Presented By

Dr Johannes Björk, University Medical Center Groningen, the Netherlands

Trial

PRIMM

Conference

UEGW 2022

2 December, 2022 09:48

Computer-aided colonoscopies improved adenoma detection rates

Presented By

Dr Michiel Maas, Raboud UMC, the Netherlands

Conference

UEGW 2022

2 December, 2022 09:44

Benefit of colon cancer screening with colonoscopy lower than anticipated

Presented By

Prof. Michael Bretthauer, Oslo University, Norway

Trial

Phase 3, NordICC

Conference

UEGW 2022

2 December, 2022 09:41

Screening-detected colorectal cancers may have superior surgical outcomes

Presented By

Dr Jannie Dressler, Bispebjerg Hospital, Denmark

Conference

UEGW 2022

2 December, 2022 09:37

Favourable pancreatitis outcomes with procalcitonin-based algorithm to guide antibiotic use

Presented By

Prof. Ajith Siriwardena, Manchester Royal Infirmary, UK

Trial

PROCAP

Conference

UEGW 2022

2 December, 2022 09:35

Fewer long-term interventions after delayed drainage in necrotising pancreatitis

Presented By

Noor Sissingh, Leiden University Medical Centre, the Netherlands

Trial

POINTER

Conference

UEGW 2022

2 December, 2022 09:24

Detection of Europe´s deadliest cancer: much room for improvement

Presented By

Dr Nosheen Umar, University of Birmingham, UK

Conference

UEGW 2022

2 December, 2022 09:21

Portal hypertension is associated with poor prognosis in cirrhotic patients

Presented By

Mr Phil Ambery, AstraZeneca, Sweden

Conference

UEGW 2022

2 December, 2022 09:18

Chances of transplant-free survival in PSC enhanced by colectomy with ileostomy

Presented By

Dr Bregje Mol, Amsterdam UMC, the Netherlands

Conference

UEGW 2022

2 December, 2022 09:13

SARS-CoV-2: Booster doses of key importance for cirrhotic patients

Presented By

Dr Samer Al-Dury, Sahlgrenska University Hospital, Sweden

Conference

UEGW 2022

2 December, 2022 09:11

Less ulcer bleeds early after H. pylori eradication in aspirin users

Presented By

Prof. Christopher Hawkey, Nottingham Digestive Diseases Centre, UK

Trial

Phase 4, HEAT

Conference

UEGW 2022

2 December, 2022 09:08

Dupilumab effective in paediatric patients with eosinophilic oesophagitis

Presented By

Prof. Evan S. Dellon, University of North Carolina School of Medicine in Chapel Hill, NC, USA

Trial

Phase 3, EoE KIDS

Conference

UEGW 2022

2 December, 2022 09:04

Neoplasia in Barrett’s oesophagus: the earlier the intervention, the better the long-term outcome

Presented By

Dr Fadi Younis, University Hospital Hamburg-Eppendorf, Germany

Conference

UEGW 2022

2 December, 2022 09:00

Fast recapture of response with ozanimod after withdrawal in UC

Presented By

Dr Anita Afzali, University of Cincinnati College of Medicine, OH, USA

Trial

Phase 3, True North

Conference

UEGW 2022

1 December, 2022 22:08

Ozanimod treatment prompted substantial response after failure of response to induction

Presented By

Prof. Remo Panaccione, University of Calgary, Canada

Trial

Phase 3, True North

Conference

UEGW 2022

1 December, 2022 22:06

Etrasimod shows advantage over placebo in UC

Presented By

Prof. Séverine Vermeire, University Hospital Leuven, Belgium

Trial

Phase 3, ELEVATE UC

Conference

UEGW 2022

1 December, 2022 22:03

Etrasimod reduces adaptive immune cells in the periphery in UC

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, ELEVATE UC

Conference

UEGW 2022

1 December, 2022 22:00

Favourable maintenance rates for risankizumab also in delayed responders with CD

Presented By

rof. Geert D’Haens, Amsterdam UMC, the Netherlands

Trial

Phase 3, FORTIFY

Conference

UEGW 2022

1 December, 2022 21:56

IL-23 inhibition reduces inflammatory biomarkers in pre-treated UC

Presented By

Prof. Julian Panés, Hospital Clínic Barcelona, Spain

Trial

Phase 2, QUASAR

Conference

UEGW 2022

1 December, 2022 21:53

Maintained symptom control with mirikizumab in UC

Presented By

Prof. Axel Dignass, Agaplesion Markus Hospital, Germany

Trial

Phase 3, LUCENT 2

Conference

UEGW 2022

1 December, 2022 21:49

Mirikizumab successfully resolves active histologic inflammation in UC

Presented By

Prof. Fernando Magro, CHU de São João, Portugal

Trial

Phase 2, LUCENT 2

Conference

UEGW 2022

1 December, 2022 21:44

Upadacitinib for CD: remarkable efficacy in induction therapy

Presented By

Prof. Julian Panés, Hospital Clínic Barcelona, Spain

Trial

Phase 3, U-EXCEL

Conference

UEGW 2022

1 December, 2022 21:42

Sustained maintenance results with upadacitinib in UC

Presented By

Prof. Séverine Vermeire, University Hospital Leuven, Belgium

Trial

U-ACHIEVE Maintenance

Conference

UEGW 2022

1 December, 2022 21:37

Start low with brepocitinib and ritlecitinib in UC

Presented By

Dr Kenneth Hung, Pfizer, MA, USA

Trial

Phase 2, VIBRATO

Conference

UEGW 2022

1 December, 2022 21:34

Another chance for TYK2 inhibition in UC

Presented By

Prof. Stephan Schreiber, University Hospital Schleswig-Holstein, Germany

Trial

Phase 2, LATTICE-UC

Conference

UEGW 2022

1 December, 2022 21:29

Small molecule obefazimod shows promise in UC

Presented By

Prof. Séverine Vermeire, University Hospital Leuven, Belgium

Conference

UEGW 2022

1 December, 2022 21:26

Pivotal results of etrolizumab for CD partly disappointing

Presented By

Prof. Séverine Vermeire, University Hospital Leuven, Belgium

Trial

Phase 3, BERGAMOT

Conference

UEGW 2022

1 December, 2022 17:27

Better results for vedolizumab in early CD

Presented By

Prof. Geert D’Haens, Amsterdam UMC, the Netherlands

Trial

Phase 4, LOVE-CD

Conference

UEGW 2022

1 December, 2022 17:19

Some patients with limited CD may benefit from an early surgical intervention

Presented By

Dr Melek Zahra Sarikaya, Sjællands Universitetshospital, Denmark

Trial

LIR!C

Conference

UEGW 2022

1 December, 2022 17:11

Dose-interval of adalimumab might be prolonged in CD patients in stable remission

Presented By

Dr Reinier van Linschoten , Franciscus Gasthuis en Vlietland, the Netherlands

Trial

Phase 4, LADI

Conference

UEGW 2022

1 December, 2022 17:01

Zuranolone shows rapid-acting efficacy in postpartum depression

Presented By

Dr Kristina Deligiannidis, Zucker Hillside Hospital, NY, USA

Trial

Phase 3, SKYLARK

Conference

ECNP 2022

28 November, 2022 11:35

Probiotics could reduce perceived stress

Presented By

Dr Julie Hudry, Nestlé Institute of Health Science, Switzerland

Conference

ECNP 2022

28 November, 2022 11:33

KarXT is effective in schizophrenic patients experiencing acute psychosis

Presented By

Dr Stephen Brannan, Karuna Therapeutics, MA, USA

Trial

Phase 3, EMERGENT-2

Conference

ECNP 2022

28 November, 2022 11:30

Low-dose ulipristal acetate is an effective treatment for PMDD

Presented By

Dr Erika Comasco, Uppsala University, Sweden

Trial

Phase 2

Conference

ECNP 2022

28 November, 2022 11:28

Endogenous oxytocin release helps the mind to deal with pain

Presented By

Stephanie Küppers, Central Institute of Mental Health Mannheim, Germany

Conference

ECNP 2022

28 November, 2022 11:24

Nitric oxide synthase genetic variant is a risk factor for suicidal behaviour

Presented By

Dr Aiste Lengvenyte, CHU Montpellier, France

Conference

ECNP 2022

28 November, 2022 11:23

Early-life gut microbiota depletion changes brain morphology and behaviour

Presented By

Caoimhe Lynch, University College Cork, Ireland

Conference

ECNP 2022

28 November, 2022 11:21

Treating intrusive memories after trauma in healthcare workers using Tetris

Presented By

Prof. Emily Holmes, Uppsala University, Sweden

Trial

GAINS

Conference

ECNP 2022

28 November, 2022 11:19

VR exposure as effective as in vivo exposure for phobia

Presented By

Prof. Peter Zwanzger, kbo-Inn-Salzach-Klinikum, Germany

Conference

ECNP 2022

28 November, 2022 11:16

Efficacy of smartphone-based treatment of bipolar disorders not (yet) validated

Presented By

Dr Maria Faurholt-Jepsen, Rigshospitalet, Denmark

Conference

ECNP 2022

28 November, 2022 11:13

Mode of action of psilocybin

Presented By

Prof. Scott Thompson, University of Colorado School of Medicine, CO, USA

Conference

ECNP 2022

28 November, 2022 11:11

Fast and sustained effect of 2 administrations of psilocybin on depression

Presented By

Dr David Erritzoe, Imperial College London, UK

Trial

Phase 2, Psilodep-RCT

Conference

ECNP 2022

28 November, 2022 11:09

Antidepressant properties of psilocybin might be related to changes in sleep

Presented By

Dr Tomas Palenicek, National Institute of Mental Health, Czech Republic

Conference

ECNP 2022

28 November, 2022 11:06

Both sex hormones and serotonin play a role in peripartum mental health

Presented By

Dr Vibe Frokjaer, Copenhagen University Hospital, Denmark

Conference

ECNP 2022

28 November, 2022 11:04

Child loss induces short- and long-term neurobiological changes

Presented By

Prof. Oliver Bosch, University of Regensburg, Germany

Conference

ECNP 2022

28 November, 2022 11:01

Reproductive state matters when looking at the female brain and drug treatment effects

Presented By

Dr Jodi Pawluski, University of Rennes, France

Conference

ECNP 2022

28 November, 2022 10:59

Different brain responses to fat and/or sugar

Presented By

Prof. Susanne la Fleur, University of Amsterdam, the Netherlands

Conference

ECNP 2022

28 November, 2022 10:55

Diabetes not related to abnormal biomarkers of Alzheimer’s disease

Presented By

Veerle van Gils, Maastricht University, the Netherlands

Conference

ECNP 2022

28 November, 2022 10:53

Oxytocin treatment induces long-lasting neurobiological adaptations in autism

Presented By

Dr Kaat Alaerts, KU Leuven, Belgium

Conference

ECNP 2022

28 November, 2022 10:50

Adding first-line pembrolizumab to CRT in locally advanced HNSCC does not significantly prolong survival or event-free survival

Presented By

Prof. Jean-Pascal Machiels, Cliniques Universitaires Saint-Luc, Belgium

Trial

Phase 3, KEYNOTE-412

Conference

ESMO 2022

17 November, 2022 01:12

5-FU-free chemotherapy combination as an alternative for first-line treatment of recurrent or metastatic HNSCC

Presented By

Dr Marcin Dzienis, Gold Coast University Hospital, Australia

Trial

Phase 4, KEYNOTE-B10

Conference

ESMO 2022

17 November, 2022 01:06

Epstein Barr virus-specific autologous cytotoxic T lymphocytes do not improve survival in nasopharyngeal carcinoma

Presented By

Dr Han Chong Toh, National Cancer Centre, Singapore

Trial

Phase 3, VANCE

Conference

ESMO 2022

17 November, 2022 01:02

OS benefit for advanced ovarian cancer patients treated with maintenance olaparib

Presented By

Prof. Isabelle Ray-Coquard, Centre Léon Bérard, France

Trial

Phase 3, PAOLA-1/ENGOT-ov25

Conference

ESMO 2022

17 November, 2022 00:57

Maintenance tegafur-uracil does not improve survival in locally advanced cervical cancer

Presented By

Prof. Keiichi Fujiwara, Saitama Medical University, Japan

Trial

GOTIC-002 LUFT

Conference

ESMO 2022

17 November, 2022 00:52

Adjuvant nivolumab plus ipilimumab does not improve survival in patients with localised RCC at high risk of relapse after nephrectomy

Presented By

Prof. Robert Motzer, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, CheckMate 914

Conference

ESMO 2022

17 November, 2022 00:46

Triple therapy improves progression-free survival in patients with advanced RCC versus dual therapy

Presented By

Prof Toni Choueiri, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, COSMIC-313

Conference

ESMO 2022

17 November, 2022 00:41

Adjuvant atezolizumab does not improve outcomes for patients with RCC and increased risk of recurrence

Presented By

Dr Axel Bex, The Royal Free London NHS Foundation Trust, UK

Trial

Phase 3, IMmotion-010

Conference

ESMO 2022

17 November, 2022 00:28

Overall survival benefit of abiraterone in mHSPC is maintained for 7 years

Presented By

Prof. Gerhardt Attard, UCL Cancer Institute London, UK

Trial

Phase 3, STAMPEDE

Conference

ESMO 2022

17 November, 2022 00:23

Limited benefit of adding long-term ADT to post-operative radiotherapy in prostate cancer

Presented By

Prof. Chris Parker, The Royal Marsden Hospital, UK

Trial

RADICALS-HD

Conference

ESMO 2022

17 November, 2022 00:17

Intensified ADT benefits biochemical progression-free survival in biochemically relapsed prostate cancer

Presented By

Dr Rahul Aggarwal, University of California San Francisco, CA, USA

Trial

Phase 3, PRESTO

Conference

ESMO 2022

17 November, 2022 00:13

Treatment with tumour-infiltrating lymphocytes for advanced melanoma outperforms ipilimumab

Presented By

Prof. John Haanen, Netherlands Cancer Institute, the Netherlands

Conference

ESMO 2022

16 November, 2022 18:29

Neoadjuvant pembrolizumab outperforms adjuvant pembrolizumab in resectable stage III–IV melanomas

Presented By

Dr Sapna Patel, MD Anderson Cancer Center, TX, USA

Trial

Phase 2, SWOG S1808

Conference

ESMO 2022

16 November, 2022 18:26

Survival-benefit of neoadjuvant T-VEC maintained over 5 years of follow-up

Presented By

Prof. Reinhard Dummer, University of Zürich, Switzerland

Trial

T-VEC

Conference

ESMO 2022

16 November, 2022 18:24

Baseline ctDNA predicts survival in resected stage III–IV melanoma

Presented By

Prof. Georgina Long, University of Sydney, Australia

Trial

Phase 3, CheckMate 915

Conference

ESMO 2022

16 November, 2022 18:21

A pathway from air pollution to lung cancer in non-smokers identified

Presented By

Prof. Charles Swanton, University College London, UK

Conference

ESMO 2022

16 November, 2022 18:17

Selective KRASG12C inhibitor sotorasib demonstrates superior PFS and ORR compared to docetaxel in previously treated patients with NSCLC

Presented By

Dr Melissa Johnson, Sarah Cannon Research Institute, TN, USA

Trial

Phase 3, CodeBreaK 200

Conference

ESMO 2022

16 November, 2022 18:14

Promising clinical activity of tepotinib plus osimertinib in NSCLC with MET amplification after progression on first-line osimertinib

Presented By

Prof. Julien Mazières, CHU de Toulouse, France

Trial

Phase 2, INSIGHT-2

Conference

ESMO 2022

16 November, 2022 18:10

High pathological responses in borderline resectable NSCLC patients after induction with dual immunotherapy and concurrent chemoradiotherapy

Presented By

Dr Idris Bahce, Amsterdam UMC, the Netherlands

Trial

Phase 2, INCREASE

Conference

ESMO 2022

16 November, 2022 18:05

Tumour infiltrating lymphocytes identify patients with immunogenic triple-negative breast cancer

Presented By

Prof. Marleen Kok, Netherlands Cancer Institute, the Netherlands)

Trial

Phase 2, BELLINI

Conference

ESMO 2022

16 November, 2022 18:01

OS benefit of abemaciclib in HR-positive/HER2-negative advanced breast cancer not (yet) statistically significant

Presented By

Prof. Matthew Goetz, Mayo Clinic Rochester, MN, USA

Trial

Phase 3, MONARCH 3

Conference

ESMO 2022

16 November, 2022 17:48

OS benefit of sacituzumab govitecan in pre-treated HR-positive/HER2-negative metastatic breast cancer

Presented By

Prof. Hope Rugo, Helen Diller Family Comprehensive Cancer Centre, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ESMO 2022

16 November, 2022 17:43

Deep learning models predict the risk of relapse and the mutational profile in GIST

Presented By

Dr Raul Perret, Institute Bergonié, France

Conference

ESMO 2022

16 November, 2022 17:40

Addition of pembrolizumab to lenvatinib does not improve OS in advanced HCC

Presented By

Prof. Richard Finn, David Geffen School of Medicine, CA, USA

Trial

Phase 3, LEAP-002

Conference

ESMO 2022

16 November, 2022 17:37

New, highly selective inhibitor of FGFR2 driver alterations and resistance mutations

Presented By

Prof. Antoine Hollebecque, Institut Gustave Roussy, France

Trial

Phase 1/2, REFOCUS

Conference

ESMO 2022

16 November, 2022 17:35

Chemo-immunotherapy in gastric cancer is more effective when administered in parallel

Presented By

Prof. Sylvie Lorenzen, Klinikum rechts der Isar, TU München, Germany

Trial

Phase 2, Moonlight

Conference

ESMO 2022

16 November, 2022 17:31

High pathological responses to neoadjuvant immune checkpoint inhibition in locally advanced dMMR colon cancer

Presented By

Dr Miriam Chalabi, Netherlands Cancer Institute, the Netherlands

Trial

NICHE-2

Conference

ESMO 2022

16 November, 2022 17:28

Fruquintinib: a potential new treatment for patients with refractory mCRC

Presented By

Prof. Nageshwara Arvind Dasari, MD Anderson Cancer Centre, TX, USA

Trial

Phase 3, FRESCO-2

Conference

ESMO 2022

16 November, 2022 17:21

Second-line avelumab is effective in patients with MSI-H/dMMR mCRC

Presented By

Prof. Julien Taieb, Hopital European George Pompidou, France

Trial

Phase 2, SAMCO-PRODIGE 54

Conference

ESMO 2022

16 November, 2022 17:13

High rate of non- or partial responders jeopardises therapeutic success in HS

Presented By

Dr Hayley Wallinger, Adelphi Real World, UK

Conference

EADV 2022

5 November, 2022 11:15

Genital psoriasis: high prevalence, often underdiagnosed

Presented By

Dr Toni Klein, University Medical Center Hamburg-Eppendorf, Germany

Conference

EADV 2022

5 November, 2022 11:12

Decreased overall survival in melanoma patients with low vitamin D

Presented By

Dr Inés Gracia-Darder, Son Espases University Hospital, Spain

Conference

EADV 2022

5 November, 2022 11:09

High potential for secukinumab as next biologic treatment for HS

Presented By

Prof. Alexandra Kimball, Harvard Medical School, MA, USA

Trial

Phase 3, SUNSHINE; SUNRISE

Conference

EADV 2022

5 November, 2022 11:06

Hidradenitis suppurativa: TYK2/JAK1 inhibitor shows promise

Presented By

Prof. Alexandra Kimball, Harvard Medical School, MA, USA

Conference

EADV 2022

5 November, 2022 11:03

Dupilumab leads to clinically relevant improvements in signs and symptoms of prurigo nodularis

Presented By

Prof. Gil Yosipovitch, University of Miami, FL, USA

Trial

Phase 2, LIBERTY-PN PRIME

Conference

EADV 2022

5 November, 2022 10:59

Nalbuphine: aspiring to become another treatment for prurigo nodularis?

Presented By

Prof. Sonja Ständer, University Medical Centre of Münster, Germany

Trial

Phase 3, PRISM

Conference

EADV 2022

5 November, 2022 10:57

Notalgia paresthetica: may κ-opioid receptor agonists be a long-awaited effective therapy?

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 2, KOMFORT

Conference

EADV 2022

5 November, 2022 10:55

Enhancing re-pigmentation rates with topical ruxolitinib in all body areas

Presented By

Prof. Thierry Passeron, University Côte d’Azur, France

Trial

Phase 3, TRuE-V1; TRuE-V2

Conference

EADV 2022

5 November, 2022 10:50

Markedly lower skin cancer risk in vitiligo patients

Presented By

Dr John Ferguson, St John’s Institute of Dermatology, UK

Conference

EADV 2022

5 November, 2022 10:47

Myths regarding “health benefit” of suntan prevail in majority of population

Presented By

Prof. Thierry Passeron, Université Côte d’Azur, France

Conference

EADV 2022

5 November, 2022 10:43

Fern extract reverses severe actinic keratosis lesions

Presented By

Dr Stefania Guida, Sapienza University of Rome, Italy

Conference

EADV 2022

5 November, 2022 10:41

Novel oral psoriasis drug maintains efficacy over 2 years

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, POETYK-PSO-1

Conference

EADV 2022

5 November, 2022 10:36

A3 adenosine receptor agonist showed modest efficacy but excellent tolerability

Presented By

Dr Kim A. Papp, Probity Medical Research, Canada

Trial

Phase 3, COMFORT

Conference

EADV 2022

5 November, 2022 10:32

Selective IL-23 inhibitor achieves long-term disease control in many patients with active PsA

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

KEEPsAKE 1; KEEPsAKE 2

Conference

EADV 2022

5 November, 2022 10:28

AI machine learning algorithm useful in early detection of PsA

Presented By

Dr Jonathan Shapiro, Maccabi Healthcare Services, Israel

Conference

EADV 2022

5 November, 2022 10:24

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2022

5 November, 2022 09:30

Topical gel plus finasteride beneficial for patients with androgenetic alopecia

Presented By

Dr Michela Starace, University of Bologna, Italy

Conference

EADV 2022

5 November, 2022 09:20

Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, CT, USA

Trial

Phase 3, THRIVE-AA1

Conference

EADV 2022

5 November, 2022 09:18

Baricitinib possible therapeutic option for children with AD

Presented By

Dr Antonio Torrelo Fernández, Hospital Infantil Universitario Niño Jesús, Spain

Trial

Phase 3, BREEZE-AD-PEDS

Conference

EADV 2022

5 November, 2022 09:15

Amlitelimab therapy leads to sustained decrease of IL-22 in AD patients

Presented By

Dr Stephan Weidinger, University Hospital Schleswig-Holstein, Germany

Conference

EADV 2022

5 November, 2022 09:10

IL-13 inhibition with lebrikizumab shows high maintenance rates in AD

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, OR, USA

Trial

Phase 3, ADvocate

Conference

EADV 2022

5 November, 2022 09:05

Does 8 weeks of emollients use prevent AD in high-risk infants?

Presented By

Prof. Alan Irvine, Trinity College Dublin, Ireland

Trial

STOP AD

Conference

EADV 2022

5 November, 2022 09:02

Roflumilast foam led to high response rates in seborrheic dermatitis

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, OR, USA

Trial

Phase 3, STRATUM

Conference

EADV 2022

5 November, 2022 09:00

Study fails to show non-inferiority of rituximab with ocrelizumab

Presented By

Dr Izanne Roos, University of Melbourne, Australia

Conference

ECTRIMS 2022

31 October, 2022 11:16

Excellent results for high-flow nasal cannula oxygen therapy in acute respiratory failure

Presented By

Prof. Gamal Agmy, Assiut University, Egypt

Conference

ERS 2022

30 October, 2022 22:14

Antifibrotic therapy may slow down FVC decline in RAILD

Presented By

Prof. Ivan Rosas, Baylor College of Medicine, TX, USA

Trial

Phase 2, TRAIL1

Conference

ERS 2022

30 October, 2022 22:11

Intravenous N-acetylcysteine performs well in hospitalised patients

Presented By

Prof. Alberto Papi, University of Ferrara, Italy

Conference

ERS 2022

30 October, 2022 22:09

Men and women respond differently to diesel exhaust

Presented By

Dr Mahadevappa Hemshekhar, University of Manitoba, Canada

Conference

ERS 2022

30 October, 2022 22:06

New trends in cystic lung diseases

Presented By

Prof. Cormac McCarthy, University College Dublin, Ireland

Conference

ERS 2022

30 October, 2022 22:04

In the spotlight: Cancer trends in obstructive sleep apnoea

Presented By

Dr Andreas Palm, Uppsala University, Sweden

Trial

DISCOVER

Conference

ERS 2022

30 October, 2022 21:56

Impact of CPAP on cardiac endpoints in OSA

Presented By

Prof. Anita Simonds, National Heart & Lung Institute, UK

Conference

ERS 2022

30 October, 2022 21:54

Sustained hypoxaemia predicts unprovoked VTE in OSA

Presented By

Prof. Wojciech Trzepizur, University of Angers, France

Conference

ERS 2022

30 October, 2022 21:50

CPAP therapy in the prevention of cardiovascular risk in patients with OSA

Presented By

Prof. Raphael Heinzer, Lausanne University Hospital, Switzerland

Trial

SAVE

Conference

ERS 2022

30 October, 2022 21:48

Head-to-head: lung volume reduction surgery vs endobronchial valves

Presented By

Ms Sara Buttery, Royal Brompton and Harefield NHS Foundation Trust, UK

Trial

CELEB

Conference

ERS 2022

30 October, 2022 21:42

Durable effect of endobronchial valves in severe emphysema

Presented By

Prof. Gerard Criner, Temple University, PA, USA

Trial

EMPROVE

Conference

ERS 2022

30 October, 2022 21:40

Cone beam CT-guided ENB improves detection of pulmonary nodules

Presented By

Prof. Benjamin Bondue, Université Libre de Bruxelles, Belgium

Conference

ERS 2022

30 October, 2022 21:37

Confirmatory mediastinoscopy not needed in resectable NSCLC

Presented By

Prof. Jouke Annema, Amsterdam UMC, the Netherlands

Trial

MEDIASTrial

Conference

ERS 2022

30 October, 2022 21:30

Antibiotics cause increased risk of wheezing in severe RSV bronchiolitis

Presented By

Prof. Avraham Beigelman, Schneider Children's Medical Center of Israel, Israel

Conference

ERS 2022

30 October, 2022 21:23

Inhaled corticosteroids useful in preterms with decreased lung function

Presented By

Prof. Shannon Simpson, Curtin University, Australia

Trial

PICSI

Conference

ERS 2022

30 October, 2022 21:19

Fish oil or vitamin D during pregnancy can prevent croup

Presented By

Dr Nicklas Brustad, University of Copenhagen, Denmark

Conference

ERS 2022

30 October, 2022 21:16

Encouraging results of nintedanib in children with fibrosing ILD

Presented By

Dr Robin Deterding, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, InPedILD

Conference

ERS 2022

30 October, 2022 21:10

Tezepelumab in asthma: mucus plugging down, lung function up

Presented By

Prof. Christopher Brightling, University of Leicester, UK

Trial

Phase 2, CASCADE

Conference

ERS 2022

30 October, 2022 21:06

Digital asthma intervention improves health and reduces costs

Presented By

Mr Luca Ponti, Amiko Digital Health, Italy

Conference

ERS 2022

30 October, 2022 21:03

Digitally enhanced therapy lowers treatment burden and costs in severe asthma

Presented By

Prof. Richard Costello, Bon Secours Hospital Dublin, Ireland

Trial

INCA-SUN

Conference

ERS 2022

30 October, 2022 21:01

Mepolizumab beneficial for patients with severe eosinophilic asthma

Presented By

Dr Rupert Jakes, GSK, UK

Trial

REALITI-A

Conference

ERS 2022

30 October, 2022 20:59

Icenticaftor achieves results on top of triple inhalation therapy in COPD

Presented By

Prof. Frits Franssen, Maastricht University, the Netherlands

Conference

ERS 2022

30 October, 2022 20:50

STARR2: A new approach for treating COPD exacerbations

Presented By

Prof. Mona Bafadhel, King’s College London, UK

Trial

Phase 4, STARR2

Conference

ERS 2022

30 October, 2022 20:48

COPD medication not effective in symptomatic smokers with preserved spirometry

Presented By

Prof. MeiLan Han, University of Michigan, MI, USA

Trial

Phase 3, RETHINC

Conference

ERS 2022

30 October, 2022 20:46

Do digital tools improve physical activity in COPD?

Presented By

Prof. Andre Nyberg, University of Umeå, Sweden

Conference

ERS 2022

30 October, 2022 20:43

Hyperpolarised gas MRI ready for clinical use

Presented By

Dr Sarah Svenningsen, McMaster University, Canada

Conference

ERS 2022

30 October, 2022 20:41

Does vilobelimab reduce mortality in severe COVID-19?

Presented By

Prof. Alexander Vlaar, Amsterdam UMC, the Netherlands

Trial

Phase 3, PANAMO

Conference

ERS 2022

30 October, 2022 20:35

Awake proning not positive in COVID-19

Presented By

Prof. Jason Weatherald, University of Alberta, Canada

Trial

COVI-PRONE

Conference

ERS 2022

30 October, 2022 20:30

Favipiravir may help patients over 60 years with COVID-19 to recover

Presented By

Dr Christopher Orton, Royal Brompton Hospital, UK

Trial

Phase 3, PIONEER

Conference

ERS 2022

30 October, 2022 20:28

Brensocatib fails in severe COVID-19

Presented By

Ms Holly Keir, University of Dundee, UK

Conference

ERS 2022

30 October, 2022 20:25

Inhaled agent under investigation for COVID-19

Presented By

Prof. Tom Wilkinson, University of Southampton, UK

Trial

Phase 3, SPRINTER

Conference

ERS 2022

30 October, 2022 20:22

Accurate voice-based COVID-19 diagnostic test in development

Presented By

Ms Wafaa Aljbawi, Maastricht University, the Netherlands

Conference

ERS 2022

30 October, 2022 20:19

Novel scoring tool for post-COVID syndrome aids clinicians and researchers

Presented By

Prof. Thomas Bahmer, University of Kiel, Germany

Conference

ERS 2022

30 October, 2022 20:16

Old dogs, new tricks: Acetazolamide plus loop diuretics improves decongestion

Presented By

Prof. Wilfried Mullens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, ADVOR

Conference

ESC 2022

27 October, 2022 14:43

No effect of neprilysin inhibition on cognition

Presented By

Prof. John McMurray, University of Glasgow, UK

Trial

Phase 3, PERSPECTIVE

Conference

ESC 2022

27 October, 2022 14:41

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Presented By

Prof. Scott Solomon, Brigham and Women's Hospital, Harvard Medical School, MA, USA

Trial

Phase 3, DELIVER

Conference

ESC 2022

27 October, 2022 14:35

Pooled analysis of DAPA-HF and DELIVER

Presented By

Prof. Pardeep Jhund, University of Glasgow, UK

Trial

Phase 3, DAPA-HF, DELIVER

Conference

ESC 2022

27 October, 2022 14:33

Meta-analysis of DELIVER and EMPEROR-Preserved

Presented By

Dr Muthiah Vaduganathan, Brigham and Women's Hospital, Harvard Medical School, MA, USA

Trial

Phase 3, DELIVER, EMPEROR-Preserved

Conference

ESC 2022

27 October, 2022 14:27

Rheumatic heart disease-associated AF: standard-of-care holds ground

Presented By

Prof. Ganesan Karthikeyan, All India Institute of Medical Sciences, India

Trial

Phase 3, INVICTUS

Conference

ESC 2022

27 October, 2022 14:14

New anticoagulant safe and maybe effective: PACIFIC-AMI and PACIFIC-Stroke outcomes

Presented By

Prof. John Alexander, Duke University, NC, USA & Prof. Ashkan Shoamanesh, McMaster University, Canada

Trial

Phase 2, PACIFIC-AMI, PACIFIC-Stroke

Conference

ESC 2022

27 October, 2022 14:02

AXIOMATIC-SSP: Reducing risk of ischaemic stroke with factor XIa inhibition?

Presented By

Dr Mukul Sharma, McMaster University, Canada

Trial

Phase 2, AXIOMATIC-SSP

Conference

ESC 2022

27 October, 2022 13:59

Evolving evidence for P2Y12 inhibition in chronic coronary syndromes: PANTHER

Presented By

Prof. Marco Valgimigli, Cardiocentro Ticino Foundation, Switzerland

Trial

PANTHER

Conference

ESC 2022

27 October, 2022 13:55

Danish study suggests starting CVD screening before age 70

Presented By

Prof. Axel Cosmus Pyndt Diederichsen, Odense University Hospital, Denmark

Trial

DANCAVAS

Conference

ESC 2022

27 October, 2022 12:59

Polypill SECUREs win in secondary prevention in elderly

Presented By

Dr Valentin Fuster, Mount Sinai Health System, NY, USA

Trial

Phase 3, SECURE

Conference

ESC 2022

27 October, 2022 12:56

Long-term therapy with evolocumab associated with lower CV mortality

Presented By

Prof. Michelle O'Donoghue, Brigham and Women's Hospital, MA, USA

Trial

FOURIER

Conference

ESC 2022

27 October, 2022 12:54

ARBs + beta-blockers may delay Marfan syndrome aortic root replacement

Presented By

Dr Alex Pitcher, Oxford University Hospitals NHS Foundation Trust, UK

Conference

ESC 2022

27 October, 2022 12:52

ENTRIGUE: Subcutaneous pegozafermin in severe hypertriglyceridaemia

Presented By

Prof. Deepak Bhatt, Harvard Medical School, MA, USA

Trial

Phase 2, ENTRIGUE

Conference

ESC 2022

27 October, 2022 12:49

First RCT evidence for use of AI in daily practice

Presented By

Dr David Ouyang, Cedars-Sinai Smidt Heart Institute, CA, USA

Trial

EchoNet-RCT

Conference

ESC 2022

27 October, 2022 12:40

AI-enhanced echography supports aortic stenosis patients

Presented By

Prof. Geoffrey Strange, University of Notre Dame, Australia

Trial

AI-ENHANCED AS

Conference

ESC 2022

27 October, 2022 12:38

Smartphones for AF detection

Presented By

Prof. Axel Bauer, Innsbruck Medical University, Austria

Trial

eBRAVE-AF

Conference

ESC 2022

27 October, 2022 12:25

Medical therapy versus PCI for ischaemic cardiomyopathy

Presented By

Prof. Divaka Perera, Guy's & St Thomas' NHS Foundation Trust, London, UK

Trial

REVIVED-BCIS2

Conference

ESC 2022

27 October, 2022 12:16

Allopurinol disappoints in ALL-HEART

Presented By

Prof. Isla Shelagh Mackenzie, University of Dundee, UK

Trial

ALL-HEART

Conference

ESC 2022

27 October, 2022 12:13

Conservative or invasive management for high-risk kidney disease patients with ischaemia?

Presented By

Prof. Sripal Bangalore, New York University School of Medicine, NY, USA

Trial

Phase 4, ISCHEMIA-CKD EXTEND

Conference

ESC 2022

27 October, 2022 12:10

Genotype-guided antiplatelet therapy in patients receiving PCI

Presented By

Dr Brenden Ingraham, Mayo Clinic, MN, USA

Trial

Phase 4, TAILOR-PCI

Conference

ESC 2022

27 October, 2022 12:06

Prevention of VT and sudden cardiac death: the new recommendations

Presented By

Prof. Katja Zeppenfeld, Leiden University Medical Center, the Netherlands & Prof. Jacob Tfelt-Hansen, Copenhagen University Hospital, Denmark

Conference

ESC 2022

27 October, 2022 11:56

New and first ESC cardio-oncology guideline

Presented By

Dr Teresa López-Fernández, La Paz University Hospital, Spain & Dr Alexander Lyon, Royal Brompton Hospital, London, UK

Conference

ESC 2022

27 October, 2022 11:54

The 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension

Presented By

Prof. Stephan Rosenkranz, Heart Center at the University Cologne, Germany & Prof. Marion Delcroix, University Hospitals Leuven, Belgium

27 October, 2022 11:47

Cardiovascular assessment and management of patients undergoing non-cardiac surgery

Presented By

Prof. Sigrun Halvorsen, Oslo University Hospital Ulleval, Norway & Prof. Julinda Mehilli, Landshut-Achdorf Hospital, Germany

Conference

ESC 2022

27 October, 2022 11:45

Take hypertension medication anyTIME

Presented By

Prof. Thomas MacDonald, University of Dundee, UK

Trial

TIME

Conference

ESC 2022

27 October, 2022 10:44

BOXing out oxygen and blood pressure targets

Presented By

Prof. Jacob Eifer Møller & Dr Jesper Kjaergaard, Copenhagen University Rigshospitalet, Denmark

Trial

BOX

Conference

ESC 2022

27 October, 2022 10:40

Coronary CT angiography diagnostics compared head-to-head

Presented By

Prof. Morten Bøttcher, Aarhus University, Denmark

Trial

DanNICAD-2

Conference

ESC 2022

27 October, 2022 10:38

High-dose influenza vaccine: mortality benefit?

Presented By

Dr Niklas Dyrby Johansen, Herlev and Gentofte Hospital, Denmark

Trial

Phase 2, DANFLU-1

Conference

ESC 2022

27 October, 2022 10:30

FFR-guided decision-making in patients with AMI and multivessel disease

Presented By

Dr Joo-Yong Hahn, Samsung Medical Center, Seoul, South Korea

Trial

FRAME-AMI

Conference

ESC 2022

27 October, 2022 10:29

Therapies for atopic dermatitis: still moving forward

Presented By

Prof. Christian Vestergaard, Aarhus University Hospital, Denmark

Conference

SPIN 2022

26 August, 2022 10:58

Children with AD: high risk of bacterial infections in carriers of a filaggrin gene variant

Presented By

Prof. Alina Suru , Carol Davila University of Medicine and Pharmacy, Romania

Conference

SPIN 2022

26 August, 2022 10:53

Men on biologics report fewer adverse events than women

Presented By

Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands

Conference

SPIN 2022

26 August, 2022 10:51

Conceptual framework of adverse drug reactions may improve treatment of patients with IMIDs

Presented By

Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands

Conference

SPIN 2022

26 August, 2022 10:49

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference

SPIN 2022

26 August, 2022 10:47

Systemic treatment for psoriasis: what is on the horizon?

Presented By

Prof. Diamant Thaci , University of Lübeck, Germany

Conference

SPIN 2022

26 August, 2022 10:45

Topical therapy in psoriasis: an important partner in combination therapy

Presented By

Prof. Peter van de Kerkhof, Radboud University Medical Centre, the Netherlands

Conference

SPIN 2022

26 August, 2022 10:40

GPP flares: pronounced undertreatment is common

Presented By

Dr Wendell Valdecantos , Boehringer Ingelheim Pharmaceuticals, CT, USA

Conference

SPIN 2022

26 August, 2022 10:38

All patients with GPP benefit from IL-36 inhibitor therapy

Trial

Phase 2, Effisayil 1

Conference

SPIN 2022

26 August, 2022 10:37

IL-17A/F inhibitor bimekizumab shows higher response and maintenance rates compared with secukinumab

Trial

Phase 3, BE RADIANT

Conference

SPIN 2022

26 August, 2022 10:35

Greater PASI reductions lead to less impairment in social and sexual life

Trial

Phase 3, VOYAGE 1, VOYAGE 2

Conference

SPIN 2022

26 August, 2022 10:32

Paediatric psoriasis: ixekizumab beneficial in difficult-to-treat areas

Presented By

Dr Marieke Seyger , Radboud University Medical Centre, the Netherlands

Trial

Phase 3, IXORA-PEDS

Conference

SPIN 2022

26 August, 2022 10:30

Psoriasis patients see great benefit in achieving complete skin clearance

Presented By

Prof. Matthias Augustin , University Medical Centre Hamburg, Germany

Conference

SPIN 2022

26 August, 2022 10:25

Predilection sites for skin signs of vitiligo disease activity determined

Presented By

Dr Liesbeth Delbaere , Ghent University Hospital, Belgium

Conference

SPIN 2022

26 August, 2022 10:24

Vitiligo-childhood onset commonly under 10 years

Conference

SPIN 2022

26 August, 2022 10:21

IHS4 better suited as an outcome measure in HS trials?

Presented By

Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway

Conference

SPIN 2022

26 August, 2022 10:18

New treatments for HS: IL-17 inhibitors next in practice?

Presented By

Dr Axel Villani, University of Lyon, France & Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway

Conference

SPIN 2022

26 August, 2022 10:05

Alopecia areata: light at the end of the tunnel

Presented By

Prof. Maryanne Senna , Harvard Medical School, MA, USA

Trial

Phase 3, BRAVE-AA1, BRAVE-AA2

Conference

SPIN 2022

26 August, 2022 10:01

Alopecia areata pathogenesis: known genetic background, unknown environmental triggers

Presented By

Prof. Rodney Sinclair , University of Melbourne, Australia

Conference

SPIN 2022

26 August, 2022 09:56

Psoriasis treatment: no elevation of MACE and VTE on deucravacitinib

Presented By

Prof. Mark Lebwohl , Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, POETYK PSO-1, POETYK PSO-2

Conference

SPIN 2022

26 August, 2022 09:50

Comorbid anxiety and depression may benefit from psoriasis treatment with certolizumab

Presented By

Prof. April Armstrong, Keck School of Medicine of USC, CA, USA

Trial

Phase 3, CIMPASI-1, CIMPASI-2

Conference

SPIN 2022

26 August, 2022 09:47

Dose tapering in psoriasis is associated with a low relapse rate

Presented By

Dr Juan Raul Castro Ayarza , Medicarte, Colombia

Conference

SPIN 2022

26 August, 2022 09:43

Tau autoimmunity associated with systemic disease

Presented By

Dr Andreia Magalhães, University of Zurich, Switzerland

Conference

EAN 2022

22 August, 2022 17:15

Long-term effects of avalglucosidase alfa in late-onset Pompe disease

Presented By

Prof. Benedikt Schoser, Friedrich Baur Institute, Germany

Trial

Phase 3, COMET

Conference

EAN 2022

22 August, 2022 17:12

European survey of patient satisfaction in the treatment of cancer-related neuropathic pain

Presented By

‪Prof. Martin Rakusa, ‬University Medical Centre Maribor, Slovenia

Conference

EAN 2022

22 August, 2022 17:09

COVID-19 elevates risk of neurodegenerative disorders

Presented By

Dr Pardis Zarifkar, Rigshospitalet, Denmark

Conference

EAN 2022

22 August, 2022 17:03

More headaches in adolescents during COVID-19 pandemic

Presented By

Dr Ayşe Nur Özdag Acarli, Ermenek State Hospital, Turkey

Conference

EAN 2022

22 August, 2022 16:59

AstraZeneca vaccination and risk of cerebral venous sinus thrombosis

Presented By

Dr Jonathan Coutinho, Amsterdam University Medical Centre, the Netherlands

Conference

EAN 2022

22 August, 2022 16:55

Large impact of COVID-19 on dementia diagnosis and care

Presented By

Prof. Bengt Winblad, Karolinska Institutet, Sweden

Conference

EAN 2022

22 August, 2022 16:49

Seizure forecasting with non- and minimally-invasive devices

Presented By

Dr Pedro Faro Viana, King's College London, UK

Conference

EAN 2022

22 August, 2022 16:44

Real-world efficacy of cenobamate in focal-onset seizures

Presented By

Dr Giovanni Falcicchio & Dr Ariadna Gifreu

Conference

EAN 2022

22 August, 2022 16:38

Possible new biomarker for early neuronal death in mesial temporal lobe epilepsy

Presented By

Mr Ricardo Martins-Ferreira, University of Porto, Spain

Conference

EAN 2022

22 August, 2022 16:33

Most acute stroke patients have undiagnosed risk factors

Presented By

Dr André Rêgo, Lausanne University Hospital and University of Lausanne, Switzerland

Conference

EAN 2022

22 August, 2022 16:27

Absence of Susceptibility Vessel Sign points to malignancy in stroke patients

Presented By

Dr Morin Beyeler, Bern University Hospital, Switzerland

Conference

EAN 2022

22 August, 2022 16:24

Acute stroke management: from time window to tissue window?

Presented By

Dr Davide Strambo, University of Lausanne, Switzerland

Conference

EAN 2022

22 August, 2022 16:20

Intestinal alterations in patients with Parkinson’s disease

Presented By

Dr Gabriele Bellini, University of Pisa, Italy

Conference

EAN 2022

22 August, 2022 16:12

Gene variants impact survival in monogenic Parkinson’s disease

Presented By

Dr Aymeric Lanore, Paris Brain Institute, France

Conference

EAN 2022

22 August, 2022 16:08

When to start, switch, and stop MS therapy: Real-world evidence counts

Presented By

Prof. Melinda Magyari, Rigshospitalet, Denmark

Conference

EAN 2022

22 August, 2022 15:36

Updated EAN-ECTRIMS guideline on pharmacological MS treatment

Presented By

Prof. Maria Pia Amato, University of Florence, Italy

Conference

EAN 2022

22 August, 2022 15:31

Gut microbiota composition associated with disability worsening

Presented By

Dr Ayla Pauwels, Vrije Universiteit Brussel, Belgium

Conference

EAN 2022

22 August, 2022 15:26

Teriflunomide in children with MS: final results of TERIKIDS

Presented By

Prof. Tanuja Chitnis, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, TERIKIDS

Conference

EAN 2022

22 August, 2022 15:22

Estimating brain age in MS: machine learning versus deep learning

Presented By

Dr Lars Skattebøl, Oslo University Hospital, Norway

Conference

EAN 2022

22 August, 2022 15:17

Ofatumumab improves cognitive processing speed

Presented By

Prof. Ralph H.B. Benedict, University at Buffalo, NY, USA

Trial

Phase 3, ASCLEPIOS I/II

Conference

EAN 2022

22 August, 2022 15:13

Targeting cortical activation by transcranial magnetic stimulation

Presented By

Dr Anna Andreou, King's College London, United Kingdom

Conference

EAN 2022

22 August, 2022 15:07

Erenumab more than doubles plasma CGRP levels

Presented By

Dr Nina Vashchenko, Sechenov First Moscow State Medical University, Russia

Conference

EAN 2022

22 August, 2022 15:03

Over a third of patients responds late to CGRP antibodies

Presented By

Dr Cinzia Aurilia, University of Florence, Italy

Conference

EAN 2022

22 August, 2022 14:59

Getting evidence into practice

Presented By

Prof. Carl Clarke & Prof. Barbara Tettenborn

Conference

EAN 2022

22 August, 2022 14:50

Physical activity improves asthma control

Presented By

Morten Hostrup, University of Copenhagen, Denmark

Conference

NLC 2022

17 August, 2022 16:30

Tailored exercise needed for COPD patients

Presented By

Prof. Andre Nyberg, Umea University, Sweden

Conference

NLC 2022

17 August, 2022 16:28

Exercise training for IPF patients is feasible but access needs to be improved

Presented By

Dr Jana de Brandt, Umeå University, Sweden

Conference

NLC 2022

17 August, 2022 16:24

Asthma increases risks around delivery

Presented By

Dr Paula Kauppi, University of Helsinki, Finland

Conference

NLC 2022

17 August, 2022 16:13

PRO-ART study: unravelling the link between asthma and subfertility

Presented By

Dr Anne Hansen, Copenhagen University Hospital, Denmark

Trial

Phase 2, PRO-ART

Conference

NLC 2022

17 August, 2022 16:10

Early-onset and uncontrolled asthma: strong association with recurrent pregnancy loss

Presented By

Dr Casper Tidemandsen, Copenhagen University Hospital, Denmark

Conference

NLC 2022

17 August, 2022 16:08

Round-up of respiratory disease and reproduction topics

Conference

NLC 2022

17 August, 2022 16:06

Advance care planning

Presented By

Prof. Mette Asbjørn Neergaard, Aarhus University, Denmark & Dr Reeta Piili, Tampere University, Finland

Conference

NLC 2022

17 August, 2022 16:01

Severe asthma in the spotlights

Presented By

Prof. Lena Uller, Lund University, Sweden

Conference

NLC 2022

17 August, 2022 15:58

Common comorbidities in severe asthma

Presented By

Dr Asger Sverrild, Bispebjerg Hospital, Denmark

Conference

NLC 2022

17 August, 2022 15:56

Switching biologicals in severe asthma

Conference

NLC 2022

17 August, 2022 15:53

Targeting treatable traits allows a personalised approach to management of (severe) asthma

Presented By

Dr Florence Schleich, University of Liège, Belgium

Conference

NLC 2022

17 August, 2022 15:44

Social distancing led to a reduced number of exacerbations in bronchiectasis patients

Conference

NLC 2022

17 August, 2022 15:42

Exercise-induced laryngeal obstruction (EILO) is often misdiagnosed

Presented By

Dr Emil Walsted, Bispebjerg Hospital, Denmark

Conference

NLC 2022

17 August, 2022 15:40

CRSwNP outlined

Presented By

Dr Sanna Toppila-Salmi, University of Helsinki, Finland

Conference

NLC 2022

17 August, 2022 15:36

The role of biologics in CRSwNP

Presented By

Prof. Lars-Olaf Cardell, Karolinska Institute, Sweden

Conference

NLC 2022

17 August, 2022 15:31

The ULANC Group: working together in CRSwNP/asthma

Presented By

Prof. Vibeke Backer, Rigshospitalet/Copenhagen University, Denmark

Conference

NLC 2022

17 August, 2022 15:29

No oral corticosteroids before a confirmed diagnosis of ILD

Conference

NLC 2022

17 August, 2022 15:27

Rheumatoid arthritis-associated ILD

Presented By

Dr Phuong Phuong Diep, Oslo University Hospital, Norway

Conference

NLC 2022

17 August, 2022 15:22

Thoracic ultrasound: a new diagnostic imaging tool in RA-ILD?

Presented By

Dr Bjørk Sofíudóttir, University of South Denmark, Denmark

Trial

AURORA

Conference

NLC 2022

17 August, 2022 15:19

Update on treatment of fibrotic ILD

Presented By

Dr Elisabeth Bendstrup, Aarhus University Hospital, Denmark

Conference

NLC 2022

17 August, 2022 15:14

The role of CPAP and HFNC in COVID-19

Conference

NLC 2022

17 August, 2022 15:12

Hypoxemia and dyspnoea

Conference

NLC 2022

17 August, 2022 15:09

Lung cancer screening in Denmark

Presented By

Dr Zaigham Saghir, University of Copenhagen, Denmark

Conference

NLC 2022

17 August, 2022 14:43

Points of interest for radiologists screening for lung cancer

Presented By

Dr Michael Brun Andersen, Copenhagen University Hospital, Denmark

Conference

NLC 2022

17 August, 2022 14:41

E-cigarettes impose detrimental effects on health

Presented By

Dr Linnea Hedman, Umeå University, Sweden

Conference

NLC 2022

17 August, 2022 14:34

Effects of passive vaping in COPD patients

Presented By

Prof. Torben Sigsgaard, Aarhus University, Denmark

Conference

NLC 2022

17 August, 2022 14:32

Vaping amongst adolescents: an alarming trend

Presented By

Dr Anu Linnansaari, University of Tampere, Finland

Conference

NLC 2022

17 August, 2022 13:54

Sarcoidosis guidelines update

Conference

NLC 2022

17 August, 2022 13:52

New antigens in sarcoidosis

Presented By

Prof. Johan Grünewald, Karolinska Institute, Sweden

Conference

NLC 2022

17 August, 2022 13:50

Fatigue syndrome in sarcoidosis

Conference

NLC 2022

17 August, 2022 13:44

Detection of latent TB infection key to preventing the spread of the disease

Presented By

Prof. Tuula Vasankari, University of Turku, Finland

Conference

NLC 2022

17 August, 2022 13:41

TB management update

Conference

NLC 2022

17 August, 2022 13:37

Bacterial decolonisation effective against radiation dermatitis

Presented By

Ms Yana Kost, Albert Einstein College of Medicine, NY, USA

Conference

ASCO 2022

5 August, 2022 15:38

New standard-of-care for cisplatin-ineligible locally advanced head and neck squamous cell carcinoma

Presented By

Prof. Vanita Noronha, Tata Memorial Hospital, India

Conference

ASCO 2022

5 August, 2022 15:35

Ifosfamide is likely to be the go-to therapy in recurrent Ewing sarcoma

Presented By

Dr Martin McCabe, University of Manchester, UK

Trial

Phase 3, rEECur

Conference

ASCO 2022

5 August, 2022 15:32

Dabrafenib plus trametinib candidates for standard-of-care in BRAF V600-mutated paediatric low-grade glioma

Presented By

Prof. Eric Bouffet, University of Toronto, Canada

Conference

ASCO 2022

5 August, 2022 15:30

Primary results of rucaparib in ovarian cancer

Presented By

Prof. Bradley Monk, University of Arizona, AZ, USA

Trial

Phase 3, ATHENA-MONO

Conference

ASCO 2022

5 August, 2022 15:28

Trabectedin not superior to chemotherapy in recurrent epithelial ovarian cancer

Presented By

Dr Domenica Lorusso, San Raffaele Scientific Institute, Italy

Trial

Phase 3, MIT023

Conference

ASCO 2022

5 August, 2022 15:25

Encouraging results of relacorilant in ovarian cancer

Presented By

Prof. Nicoletta Colombo, University of Milan, Italy

Conference

ASCO 2022

5 August, 2022 15:23

Panitumumab beats bevacizumab in RAS wildtype left-sided metastatic colorectal cancer

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO 2022

5 August, 2022 15:19

Spectacular results for dostarlimab in mismatch repair deficient rectal cancer

Presented By

Dr Andrea Cercek, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO 2022

5 August, 2022 15:14

Triplet chemotherapy beats doublet chemotherapy in colorectal cancer liver metastases

Presented By

Prof. Cornelis Punt, University Medical Center Utrecht, the Netherlands

Trial

Phase 3, CAIRO5

Conference

ASCO 2022

5 August, 2022 15:11

To resect or not to resect primary tumours in stage IV colon cancer?

Presented By

Prof. Jürgen Weitz, Technische Universität Dresden, Germany

Trial

SYNCHRONOUS

Conference

ASCO 2022

5 August, 2022 15:08

Novel treatment option for KRAS wildtype pancreatic cancer

Presented By

Prof. Shukui Qin, Cancer Center of Jinling Hospital, China

Trial

Phase 3, NOTABLE

Conference

ASCO 2022

5 August, 2022 15:03

Autologous stem cell transplantation plus RVd improves PFS in multiple myeloma

Presented By

Prof. Paul Richardson, Harvard Medical School, MA, USA

Trial

Phase 3, DETERMINATION

Conference

ASCO 2022

5 August, 2022 14:33

Novel first-line treatment option for mantle cell lymphoma

Presented By

Prof. Michael Wang, Anderson Cancer Center, TX, USA

Trial

Phase 3, SHINE

Conference

ASCO 2022

5 August, 2022 14:30

Promising results for novel CAR-T therapy in relapsed/refractory multiple myeloma

Presented By

Prof. Juan Du, Shanghai Chang Zheng Hospital, China

Conference

ASCO 2022

5 August, 2022 14:24

Exploratory treatment options fail in ccRCC

Presented By

Prof. Thomas Powles, University of London, UK

Trial

Phase 2, CALYPSO

Conference

ASCO 2022

5 August, 2022 14:18

Adjuvant everolimus did not benefit high-risk renal cell carcinoma

Presented By

Dr Christopher W. Ryan, Oregon Health & Science University, OR, USA

Trial

Phase 3, EVEREST

Conference

ASCO 2022

5 August, 2022 14:14

Cabozantinib fails as first-line maintenance therapy in urothelial cancer

Presented By

Prof. Robert Jones, University of Glasgow, UK

Trial

Phase 2, ATLANTIS

Conference

ASCO 2022

5 August, 2022 14:11

177Lu-PSMA-617 is a valid treatment option for PSMA-positive mCRPC

Presented By

Prof. Michael Hofman, Peter McCallum Cancer Centre, Australia

Trial

Phase 2, TheraP

Conference

ASCO 2022

5 August, 2022 14:08

Enzalutamide performs well in metastatic hormone-sensitive prostate cancer

Presented By

Prof. Ian Davis, Monash University, Australia

Trial

Phase 3, ENZAMET

Conference

ASCO 2022

5 August, 2022 14:04

First results on distant metastasis-free survival in stage II melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 3, KEYNOTE-716

Conference

ASCO 2022

5 August, 2022 13:54

Higher response rates for concurrent triple therapy versus sequential therapy in melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 2, NeoTrio

Conference

ASCO 2022

5 August, 2022 13:50

Additional tiragolumab does not help patients with untreated small cell lung cancer

Presented By

Dr Charles Rudin, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, SKYSCRAPER-02

Conference

ASCO 2022

5 August, 2022 12:42

Success for serplulimab plus chemotherapy in small cell lung cancer

Presented By

Prof. Ying Cheng, Jilin Cancer Hospital, China

Trial

Phase 3, ASTRUM-005

Conference

ASCO 2022

5 August, 2022 12:38

Adagrasib safe and clinically active in non-small cell lung cancer

Presented By

Dr Alexander Spira, Virginia Cancer Specialists Research Institute, VA, USA

Trial

Phase 2, KRYSTAL-1

Conference

ASCO 2022

5 August, 2022 12:33

Long-term benefits of combined immunotherapy over chemotherapy in non-small cell lung cancer

Presented By

Prof. Julie Brahmer, Sidney Kimmel Comprehensive Cancer Center, Australia

Trial

Phase 3, CheckMate 227

Conference

ASCO 2022

5 August, 2022 12:29

Effect of KRAS mutations and PD-L1 expression on therapy response in non-small cell lung cancer

Presented By

Dr Oladimeji Akinboro, US Food and Drug Administration, MD, USA

Conference

ASCO 2022

5 August, 2022 12:26

Sacituzumab govitecan meets primary endpoint

Presented By

Prof. Hope Rugo, University of California San Francisco, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ASCO 2022

5 August, 2022 12:11

Shaky OS results of palbociclib in ER-positive/HER2-negative breast cancer

Presented By

Prof. Richard Finn, David Geffen School of Medicine at UCLA, CA, USA

Trial

Phase 3, PALOMA-2

Conference

ASCO 2022

5 August, 2022 12:09

Practice-changing results of T-DXd in HER2-low breast cancer

Presented By

Prof. Shanu Modi, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, DESTINY-Breast04

Conference

ASCO 2022

5 August, 2022 12:04

SET2,3 to inform on chemotherapy decisions in ER-positive breast cancer

Presented By

Dr Otto Metzger, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, CALGB9741

Conference

ASCO 2022

5 August, 2022 11:59

Metastasis-directed therapy fails in oligometastatic breast cancer

Presented By

Dr Steven Chmura, University of Chicago, IL, USA

Trial

Phase 2, NRG-BR002

Conference

ASCO 2022

5 August, 2022 11:34

Analysis by residual cancer burden further clarifies effect of pembrolizumab

Presented By

Prof. Lajos Pusztai, Yale School of Medicine, CT, USA

Trial

Phase 3, KEYNOTE-522

Conference

ASCO 2022

5 August, 2022 11:26

Contribution of metastatic therapies on mortality reduction in breast cancer

Presented By

Prof. Jennifer Caswell-Jin, Stanford University, CA, USA

Conference

ASCO 2022

5 August, 2022 11:19

Radiotherapy may be omitted in breast cancer patients

Presented By

Prof. Timothy Whelan, McMaster University, Canada

Trial

LUMINA

Conference

ASCO 2022

5 August, 2022 10:59

Promising data for ribociclib after progression on ET plus CDK4/6 inhibitors in HR-positive/HER2-negative metastatic breast cancer

Presented By

Prof. Kevin Kalinsky, Winship Cancer Institute of Emory University, GA, USA

Trial

Phase 2, MAINTAIN

Conference

ASCO 2022

5 August, 2022 10:53

7-gene biosignature: Benefits of endocrine therapy and radiotherapy in breast cancer risk groups

Presented By

Dr Pat Whitworth, Nashville Breast Cancer Center, TN, USA

Conference

ASCO 2022

5 August, 2022 10:44

GALACTIC-HF: Omecamtiv mecarbil as option for HFrEF patients with low SBP

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

Phase 3, GALACTIC-HF

Conference

HFA 2022

28 July, 2022 12:19

HELIOS-A: Vutrisiran meets exploratory endpoints

Presented By

Dr Pablo García-Pavía , Hospital Universitario Puerta de Hierro Majadahonda, Spain

Trial

Phase 4, HELIOS-A

Conference

HFA 2022

28 July, 2022 12:16

Patiromer helps HFrEF patients to optimise RAAS inhibitors without hyperkalaemia

Presented By

Prof. Stefan Anker, Charité Campus Virchow Clinic Berlin, Germany & Dr Javed Butler, Baylor University Medical Center, TX, USA

Trial

Phase 3, DIAMOND

Conference

HFA 2022

28 July, 2022 12:13

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By

Prof. Gerasimos Filippatos , Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD, FIGARO-DKD

Conference

HFA 2022

28 July, 2022 12:09

DAPA-VO2: Rapid effect of dapagliflozin on peak VO2 in stable HFrEF

Presented By

Prof. Julio Núñez Villota , University of Valencia, Spain

Trial

Phase 4, DAPA-VO2

Conference

HFA 2022

28 July, 2022 12:04

Significant improvement in BP from istaroxime, a novel non-adrenergic agent

Presented By

Prof. Marco Metra , University of Brescia, Italy

Trial

Phase 2, SEISMiC

Conference

HFA 2022

28 July, 2022 11:55

SERENADE: Macitentan fails in HFpEF plus PAH

Presented By

Prof. Adriaan Voors , University of Groningen, the Netherlands

Trial

Phase 2, SERENADE

Conference

HFA 2022

28 July, 2022 11:49

Ghrelin improves cardiac output in HFrEF

Presented By

Prof. Lars Lund, Karolinska Institutet, Sweden

Trial

Phase 2, MetaAnEnd-HF

Conference

HFA 2022

28 July, 2022 11:47

Combination of filgrastim and dutogliptin appears safe in STEMI

Presented By

Prof. Markus Wallner , Medical University of Graz, Austria

Trial

Phase 2

Conference

HFA 2022

28 July, 2022 11:44

Cardiac contractility modulation therapy promising for patients with HFpEF

Presented By

Prof. Cecilia Linde , Karolinska University Hospital, Sweden

Trial

CCM-HFpEF

Conference

HFA 2022

28 July, 2022 11:37

REBALANCE-HF: Encouraging observations for splanchnic nerve ablation in HFpEF

Presented By

Prof. Marat Fudim , Duke Cardiology Clinic, NC, USA

Trial

REBALANCE-HF

Conference

HFA 2022

28 July, 2022 11:34

DAPA-HF: Dapagliflozin is safe and efficacious in frail patients

Presented By

Dr Jawad Haider Butt , Copenhagen University Hospital, Denmark

Trial

Phase 3, DAPA-HF

Conference

HFA 2022

28 July, 2022 11:29

EMPEROR-Preserved: Empagliflozin stable across age groups

Presented By

Prof. Michael Böhm , University of the Saarland, Germany

Trial

Phase 3, EMPEROR-Preserved

Conference

HFA 2022

28 July, 2022 11:26

EMPULSE: Empagliflozin delivers rapid and clinically meaningful decongestion

Presented By

Prof. Piotr Ponikowski , Medical University of Wroclaw, Poland

Trial

Phase 3, EMPULSE

Conference

HFA 2022

28 July, 2022 11:23

Dapagliflozin performs consistently across LVEF in HF

Presented By

Dr Mikhail Kosiborod , St. Luke’s Hospital, MO, USA

Trial

Phase 4, DEFINE-HF, PRESERVED-HF

Conference

HFA 2022

28 July, 2022 11:21

Cardiac wasting relevant for clinical outcomes in cancer

Presented By

Dr Alessia Lena , Charité Universitätsmedizin Berlin, Germany

Conference

HFA 2022

28 July, 2022 10:45

Urocortin-2 a potential treatment target for HFpEF

Presented By

Ms Inês Vasconcelos, Medicine University of Porto, Portugal

Conference

HFA 2022

28 July, 2022 10:43

Should ATTR-CM be added to the differential diagnosis of patients with HF?

Presented By

Dr Rocío Ruiz Hueso , University Hospital of Virgen Macarena, Spain

Trial

PREVAMIC

Conference

HFA 2022

28 July, 2022 10:38

Delayed initiation of novel GDMTs associated with adverse outcomes in HF patients

Presented By

Prof. Gianluigi Savarese , Karolinska University Hospital, Sweden

Trial

EVOLUTION-HF

Conference

HFA 2022

28 July, 2022 10:36

Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease

Presented By

Prof. Luca Quartuccio, University of Udine, Italy

Conference

EULAR 2022

21 July, 2022 19:31

High prevalence of fibromyalgia in patients with inflammatory bowel disease

Presented By

Dr Laura Guida , Luigi Sacco University Hospital, Italy

Conference

EULAR 2022

21 July, 2022 19:27

Inhibition of Bruton’s tyrosine kinase: a new way of approaching SLE?

Presented By

Prof. Zangou Li , Peking University People’s Hospital, China

Conference

EULAR 2022

21 July, 2022 19:21

Pregnancies in SLE: many complications for mothers and their unborn children

Presented By

Prof. Bella Mehta , Weill Cornell Medical College, NY, USA

Conference

EULAR 2022

21 July, 2022 19:16

Lupus nephritis: Efficient treatment may reduce the risk of kidney disease advancement

Presented By

Prof. Konstantinos Tselios , McMaster University, Canada

Conference

EULAR 2022

21 July, 2022 18:10

Antifibrotic therapy with nintedanib is beneficial for patients with negative prognostic factors

Presented By

Prof. Christopher Denton , University College London, United Kingdom

Trial

Phase 3, SENSCIS

Conference

EULAR 2022

21 July, 2022 18:07

New treatments in osteoarthritis

Presented By

Prof. Tonia Vincent , University of Oxford, United Kingdom

Conference

EULAR 2022

21 July, 2022 18:01

OA associated with alcohol and drug abuse

Presented By

Dr Anne Kamps, Erasmus University Medical Center, the Netherlands

Conference

EULAR 2022

21 July, 2022 17:55

Body mass index increase associated with structural changes in knee OA

Presented By

Dr Zubeyir Salis, University of New South Wales, Australia

Conference

EULAR 2022

21 July, 2022 17:52

How to treat enthesitis in 2022

Presented By

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Trial

Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H

Conference

EULAR 2022

21 July, 2022 17:42

Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib

Presented By

Prof. Lars Erik Kristensen , Copenhagen University Hospital, Denmark

Conference

EULAR 2022

21 July, 2022 17:30

Treat-to-target dose reduction effective in spondyloarthritis

Presented By

Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands

Conference

EULAR 2022

21 July, 2022 17:21

A novel oral treatment possibility for non-radiographic axSpA on the horizon

Presented By

Prof. Filip van den Bosch , Ghent University, Belgium

Trial

Phase 3, SELECT-AXIS 2

Conference

EULAR 2022

21 July, 2022 17:17

Many RA and PsA patients have problems with their sex life

Presented By

Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain

Conference

EULAR 2022

21 July, 2022 17:12

Comorbid depression comes with a profoundly higher mortality risk in RA

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

21 July, 2022 15:10

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By

Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands

Trial

TREAT EARLIER

Conference

EULAR 2022

21 July, 2022 15:07

Risk factors for dementia in RA patients discovered

Presented By

Prof. Elena Myasoedova , Mayo Clinic, MN, USA

Conference

EULAR 2022

21 July, 2022 15:02

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By

Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France

Conference

EULAR 2022

21 July, 2022 14:52

TYK2 inhibition: the future of treating lupus erythematosus?

Presented By

Prof. Eric Morand , Monash University, Australia

Trial

Phase 2, PAISLEY

Conference

EULAR 2022

21 July, 2022 14:45

Psoriatic arthritis: significant improvement with bimekizumab

Presented By

Prof. Iain McInnes , Glasgow University, United Kingdom

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2022

21 July, 2022 14:36

Baricitinib could open the door to oral treatment for juvenile idiopathic arthritis

Presented By

Prof. Athimalaipet Ramanan , Bristol Medical School, United Kingdom

Trial

Phase 3, JUVE-BASIS

Conference

EULAR 2022

21 July, 2022 14:22

SPRINTER: SNG001 still in the running?

Presented By

Dr Philip Monk , Synairgen Research LtD, UK

Trial

Phase 3, SPRINTER

Conference

ATS 2022

18 July, 2022 14:04

Nebulised aviptadil “futile” in I-SPY COVID-19 trial

Presented By

Prof. Carolyn Calfee, University of California at San Francisco, CA, USA

Trial

Phase 2, I-SPY COVID-19

Conference

ATS 2022

18 July, 2022 14:01

Lung transplantation after COVID-19-associated ARDS

Presented By

Prof. G.R. Scott Budinger, Northwestern University, IL, USA

Conference

ATS 2022

18 July, 2022 13:59

COVI-PRONE trial on its back

Presented By

Prof. Waleed Alhazzani, McMaster University, Canada

Trial

COVI-PRONE

Conference

ATS 2022

18 July, 2022 13:57

Mesenchymal stem cells offer no benefit in COVID-19

Presented By

Dr Ellen Gorman, Queen’s University Belfast, UK

Trial

Phase 2, REALIST-COVID

Conference

ATS 2022

18 July, 2022 13:55

Alpha-1 antitrypsin for ARDS secondary to severe COVID-19

Presented By

Dr Oliver McElvaney, Royal College of Surgeons, Ireland

Trial

Phase 2

Conference

ATS 2022

18 July, 2022 13:53

Frailty prevalent 5 months following hospitalisation for COVID-19

Presented By

Dr Hamish McAuley, University of Leicester, UK

Trial

PHOSP-COVID

Conference

ATS 2022

18 July, 2022 13:51

Paediatric long COVID lacks definitions

Presented By

Ms Nadia Baalbaki, Emma Children’s Hospital, the Netherlands

Conference

ATS 2022

18 July, 2022 13:49

MANDALA and DENALI pattern success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy & Dr Bradley Chipps, Capital Allergy & Respiratory Disease Center, CA, USA

Trial

Phase 3, MANDALA, DENALI

Conference

ATS 2022

18 July, 2022 13:05

ACOUSTICS data sounds good for adolescent asthma exacerbations

Presented By

Prof. Stanley Szefler, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, ACOUSTICS

Conference

ATS 2022

18 July, 2022 13:02

Type 2 asthma in children managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

18 July, 2022 13:00

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

18 July, 2022 12:57

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

18 July, 2022 12:55

Three’s a crowd for triple therapy in COPD

Presented By

Prof. Claus Vogelmeier, Philipps-University Marburg, Germany

Conference

ATS 2022

18 July, 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By

Dr Snigdha Jain, Yale School of Medicine, CT, USA

Conference

ATS 2022

18 July, 2022 12:39

Reducing dyspnoea in chronic lung disease through weight loss

Presented By

Dr Maria Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

18 July, 2022 12:37

CT-evident mucus plugs in COPD associated with death

Presented By

Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA

Trial

COPDGene

Conference

ATS 2022

18 July, 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By

Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

18 July, 2022 12:33

Novel P2X3 antagonist can SOOTHE chronic cough

Presented By

Prof. Jaclyn Smith, University of Manchester, UK

Trial

Phase 2, SOOTHE

Conference

ATS 2022

18 July, 2022 12:01

Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis

Presented By

Dr Charles Haworth, Royal Papworth Hospital, UK

Trial

Phase 3, PROMIS

Conference

ATS 2022

18 July, 2022 11:59

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By

Prof. Ulrich Specks, Mayo Clinic, MN, USA

Trial

Phase 3, ADVOCATE

Conference

ATS 2022

18 July, 2022 11:56

PAGANINI phase 2b data promising for eliapixant

Presented By

Prof. Peter Dicpinigaitis, Albert Einstein College of Medicine, NY, USA

Trial

Phase 2, PAGANINI

Conference

ATS 2022

18 July, 2022 11:54

New guidelines for IPF and PPF

Presented By

Dr Elizabeth Renzoni, Royal Brompton Hospital, UK

Conference

ATS 2022

18 July, 2022 11:52

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ATS 2022

18 July, 2022 11:48

Obstructive sleep apnoea in most children with pulmonary hypertension

Presented By

Dr Daniel Ignatiuk, Cincinnati Children’s Hospital, OH, USA

Conference

ATS 2022

18 July, 2022 11:45

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

18 July, 2022 11:44

Novel PDE4B inhibitor offers breakthrough for IPF

Presented By

Prof. Luca Richeldi, Università Cattolica del Sacro Cuore, Italy

Trial

Phase 2

Conference

ATS 2022

18 July, 2022 11:42

Hydrocortisone does not help preterm infants

Presented By

Prof. Namasivayam Ambalavanan, University of Alabama, AL, USA

Trial

Phase 3, Hydrocortisone and Extubation

Conference

ATS 2022

18 July, 2022 11:38

CPAP temporarily supports pulmonary oxygenation in morbidly obese patients

Presented By

Dr Felix Girrbach, University Hospital of Leipzig, Germany

Conference

ATS 2022

18 July, 2022 11:36

ISAACC trial: CPAP controls blood pressure in ACS patients with severe OSA

Presented By

Dr Manuel Sánchez De La Torre, Lleida Biomedical Research Institute, Spain

Trial

ISAACC

Conference

ATS 2022

18 July, 2022 11:34

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux; Dr Maura Marcucci, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ACC 2022

15 June, 2022 15:34

Treating chronic mild hypertension during pregnancy leads to better outcomes

Presented By

Prof. Alan Tita, University of Alabama, USA

Trial

CHAP

Conference

ACC 2022

15 June, 2022 15:28

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By

Dr Mark Svet, University of Colorado, USA

Trial

VOYAGER-PAD

Conference

ACC 2022

15 June, 2022 15:24

Alirocumab significantly reduces high-risk coronary plaques

Presented By

Prof. Lorenz Räber, Bern University Hospital, Switzerland

Trial

Phase 3, PACMAN-AMI

Conference

ACC 2022

15 June, 2022 15:20

Aggressive warming during non-cardiac surgery does not improve outcomes

Presented By

Prof. Daniel Sessler, Cleveland Clinic, USA

Trial

PROTECT

Conference

ACC 2022

15 June, 2022 15:15

DIAMOND trial: Patiromer lowers risk of severe hyperkalaemia

Presented By

Prof. Javed Butler, University of Mississippi, MS, USA

Trial

Phase 3, DIAMOND

Conference

ACC 2022

15 June, 2022 15:12

Replacing septal reduction therapy with mavacamten for HCM

Presented By

Prof. Milind Desai, Cleveland Clinic, USA

Trial

Phase 3, VALOR-HCM

Conference

ACC 2022

15 June, 2022 15:08

Surprise outcome for SODIUM-HF

Presented By

Prof. Justin Ezekowitz, University of Alberta, Canada

Trial

Phase 3, SODIUM-HF

Conference

ACC 2022

15 June, 2022 15:03

Sotagliflozin SCORED MACE benefit

Presented By

Prof. Deepak Bhatt, Brigham and Women's Hospital, USA

Trial

Phase 3, SCORED

Conference

ACC 2022

15 June, 2022 14:57

Omecamtiv mecarbil does not impact exercise capacity of patients with HFrEF

Presented By

Prof. Michael Felker, Duke Clinical Research Institute, USA

Trial

Phase 3, METEORIC-HF

Conference

ACC 2022

15 June, 2022 14:50

Symptomatic obstructive hypertrophic cardiomyopathy: long-term mavacamten control

Presented By

Prof. Florian Rader, Cedars-Sinai Medical Center, CA, USA

Trial

MALVA-LTE

Conference

ACC 2022

15 June, 2022 14:47

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

15 June, 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By

Dr Frederik Zimmermann, Catharina Hospital, the Netherlands

Trial

FAME 3

Conference

ACC 2022

15 June, 2022 14:19

1-year CLASP TR results support tricuspid regurgitation repair

Presented By

Prof. Adam Greenbaum, Emory University School of Medicine, USA

Trial

CLASP TR

Conference

ACC 2022

15 June, 2022 14:14

Head-to-head: post-TAVR edoxaban not better than DAPT

Presented By

Prof. Duk-Woo Park, Asan Medical Center, Korea

Trial

Phase 4, ADAPT-TAVR

Conference

ACC 2022

15 June, 2022 14:09

Chocolate Touch vs Lutonix catheters

Presented By

Prof. Mehdi Shishehbor, Harrington Heart & Vascular Institute, USA

Trial

Chocolate Touch

Conference

ACC 2021

15 June, 2022 13:53

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By

Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea

Trial

FLAVOUR

Conference

ACC 2022

15 June, 2022 13:49

Low-resource countries benefit from global STEMI initiative

Presented By

Prof. Cesar Herrera, Montefiore-Einstein Center for Heart and Vascular Care, USA

Trial

GHATI

Conference

ACC 2022

15 June, 2022 13:44

Sodium thiosulfate ineffective at cardiac protection

Presented By

Dr Marie-Sophie de Koning, University Medical Center Groningen, the Netherlands

Trial

Phase 2, GIPS-IV

Conference

ACC 2022

15 June, 2022 13:40

ICM-guided management did not improve MACE after MI

Presented By

Prof. Christian Jøns, Rigshospitalet, Denmark

Trial

BIO|GUARD-MI

Conference

ACC 2022

15 June, 2022 13:36

PACIFIC-AF: Low bleeding rates for asundexian in atrial fibrillation

Presented By

Prof. Manesh Patel, Duke University School of Medicine, USA

Trial

Phase 2, PACIFIC-AF

Conference

ACC 2022

15 June, 2022 13:31

RCT-IVVE trial: Do HF patients benefit from annual flu shots?

Presented By

Prof. Mark Loeb, McMaster University, Canada

Trial

Phase 4, RCT-IVVE

Conference

ACC 2022

15 June, 2022 13:26

TRANSLATE-TIMI 70: Primary endpoint met but safety concerns for vupanorsen

Presented By

Dr Brian Bergmark, Brigham and Women’s Hospital, USA

Trial

Phase 2, TRANSLATE-TIMI 70

Conference

ACC 2022

15 June, 2022 13:21

Lipoprotein(a) slashed by 98% in APOLLO trial

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1, APOLLO

Conference

ACC 2022

15 June, 2022 13:16

Dietary intervention from your supermarket

Presented By

Prof. Dylan Steen, University of Cincinnati, OH, USA

Trial

SuperWIN

Conference

ACC 2022

15 June, 2022 13:05

Cognitive, EEG, and MRI features in COVID-19 survivors

Presented By

Dr Giordano Cecchetti, Vita-Salute San Raffaele University, Italy

Conference

AAN 2022

2 June, 2022 17:41

Neurological manifestations of COVID-19 worsen prognosis

Presented By

Dr Anna Cervantes-Arslanian, Boston University School of Medicine, MA, USA

Conference

AAN 2022

2 June, 2022 17:35

New evidence for biological basis of “COVID-19 brain fog”

Presented By

Dr Joanna Hellmuth, University of California, CA, USA

Conference

AAN 2022

2 June, 2022 17:26

Prasinezumab in Parkinson’s disease: delayed-start analysis of PASADENA trial

Presented By

Dr Gennaro Pagano, King’s College London, UK

Trial

Phase 2, PASADENA

Conference

AAN 2022

2 June, 2022 17:18

IPX203 versus immediate release carbidopa-levodopa

Presented By

Prof. Robert Hauser, USF Parkinson's Disease and Movement Disorders Center, FL, USA

Trial

Phase 3, RISE-PD

Conference

AAN 2022

2 June, 2022 17:12

Impact of COVID-19 public health interventions

Presented By

Mr Ari Vandersluis, Heritage College of Osteopathic Medicine, OH, USA

Conference

AAN 2022

2 June, 2022 17:07

Intravenous thrombolysis after ischaemic stroke: When in doubt, leave it out?

Presented By

Dr Natalie LeCouffe, Amsterdam University Medical Centre, the Netherlands

Trial

Phase 3, MR CLEAN-NO IV

Conference

AAN 2022

2 June, 2022 17:03

Better outcomes with mechanical thrombectomy in elderly stroke patients

Presented By

Dr Aisha Ali, University of Illinois, IL, USA

Conference

AAN 2022

2 June, 2022 16:59

Plasma NfL levels associated with cardiovascular risk

Presented By

Dr Hugo Aparicio, Boston University School of Medicine, MA, USA

Conference

AAN 2022

2 June, 2022 16:47

Non-invasive vagus nerve stimulation for acute stroke

Presented By

Prof. Ethem Murat Arsava, Hacettepe University, Turkey

Conference

AAN 2022

2 June, 2022 16:42

Ravulizumab in patients with generalised myasthenia gravis

Presented By

Dr Tuan Hoang Vu, University of South Florida Physicians Group, FL, USA

Trial

Phase 3, CHAMPION MG

Conference

AAN 2022

2 June, 2022 16:33

Gene therapy effective in older patients with spinal muscular atrophy

Presented By

Prof. Laurent Servais, MDUK Oxford Neuromuscular Centre, UK

Trial

RESTORE

Conference

AAN 2022

2 June, 2022 16:27

Losmapimod for facioscapulohumeral muscular dystrophy

Presented By

Prof. Al-Rabi N. Tawil, University of Rochester, NY, USA

Trial

ReDUX4

Conference

AAN 2022

2 June, 2022 16:22

SRP-9001 for treating patients with Duchenne muscular dystrophy

Presented By

Dr Jerry Mendell, Nationwide Children's Hospital, OH, USA

Conference

AAN 2022

2 June, 2022 16:17

Ublituximab versus teriflunomide in relapsing MS patients

Presented By

Prof. Lawrence Steinman, Stanford University, CA, USA

Trial

Phase 3, ULTIMATE I; ULTIMATE II

Conference

AAN 2022

2 June, 2022 16:07

Ketogenic diet may improve disability and quality of life

Presented By

Dr James Nicholas Brenton, University of Virginia Medical Center, VA, USA

Conference

AAN 2022

2 June, 2022 15:53

Favourable additional safety data for ofatumumab

Presented By

Prof. Stephen Hauser, University of California, CA, USA

Trial

Phase 3, ALITHIOS

Conference

AAN 2022

2 June, 2022 15:45

Predicting new T2 lesions using a machine learning algorithm

Presented By

Mr Bastien Caba, Biogen Digital Health, MA, USA

Trial

Phase 3, ADVANCE; ASCEND

Conference

AAN 2022

2 June, 2022 15:38

Evobrutinib reduces volume of slowly expanding lesions

Presented By

Prof. Douglas Arnold, McGill University, Canada

Conference

AAN 2022

2 June, 2022 15:34

Sustained long-term efficacy and safety of satralizumab in NMOSD

Presented By

Prof. Jeffrey Bennett, University of Colorado Hospital, CO, USA

Trial

Phase 3, SAkuraSky; SAkuraStar

Conference

AAN 2022

2 June, 2022 15:29

Migraine may be an important obstetric risk factor

Presented By

Dr Alexandra Purdue-Smithe, Harvard Medical School, MA, USA

Conference

AAN 2022

2 June, 2022 14:57

Intranasal zavegepant safe and well tolerated in healthy adults

Presented By

Prof. Richard Bertz, University of Pittsburgh, PA, USA

Conference

AAN 2022

2 June, 2022 14:52

Telemedicine during COVID-19 pandemic highly appreciated

Presented By

Dr Chia-Chun Chiang, Mayo Clinic, MN, USA

Conference

AAN 2022

2 June, 2022 14:38

“Women with epilepsy should be encouraged to breastfeed”

Presented By

Prof. Kimford Meador, Stanford Comprehensive Epilepsy Center, CA, USA

Trial

MONEAD

Conference

AAN 2022

2 June, 2022 13:52

Fenfluramine: possible new treatment for Lennox-Gastaut syndrome

Presented By

Dr Kelly Knupp, Children's Hospital Colorado, CO, USA

Conference

AAN 2022

2 June, 2022 13:42

Laser interstitial thermal therapy for refractory epilepsy

Presented By

Prof. Varun Kumar, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

AAN 2022

2 June, 2022 13:17

Targeting senescent cells to treat age-related diseases

Presented By

Dr Miranda Orr, Wake Forest School of Medicine, NC, USA

Trial

Phase 2, StoMP-AD

Conference

AAN 2022

2 June, 2022 12:29